JTWealth的个人主页 - 老虎社区

JTWealth

JTWealth

暂无个人介绍

IP属地：未知

32关注

7粉丝

0主题

0勋章

2021-11-12

Good read, but take it with a pinch of salt

The Smartest Stocks to Buy With $20 Right Now

2021-10-26

Tesla for the win

抱歉，原内容已删除

2021-10-15

Not every earnings season is the same, and most forecast dun run true

This Earnings Season Was Supposed to Be Terrible. It’s Turning Out Pretty Good.

2021-10-07

True investors would have a tough mentality and are able to ride out market volatility. The weaker ones would sell at a loss and suffer

Stocks Set to Fall Again: Is This the Secret to Making Money When Markets Plunge?

2021-10-06

$PLTR oh yeah!!

抱歉，原内容已删除

2021-09-30

Well, a good read

3 Vanguard ETFs I'm Buying if the Stock Market Crashes

2021-09-30

Oh yeahhh

抱歉，原内容已删除

2021-09-28

Aaple Ftw!

抱歉，原内容已删除

2021-09-27

Duolingo is worth a look

3 Stocks We're Ready to Buy if the Market Crashes This Month

2021-09-26

What did i just see?? Wow

抱歉，原内容已删除

2021-09-26

Oh yeahhhh

抱歉，原内容已删除

2021-09-25

There’s always ups and downs, fundamentally still strong

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3585005453956722,"uuid":"3585005453956722","gmtCreate":1621912615950,"gmtModify":1622210987673,"name":"JTWealth","pinyin":"jtwealth","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":7,"headSize":32,"tweetSize":29,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.08","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.79%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":879290034,"gmtCreate":1636725799060,"gmtModify":1636725799135,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good read, but take it with a pinch of salt","listText":"Good read, but take it with a pinch of salt","text":"Good read, but take it with a pinch of salt","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879290034","repostId":"2182094779","repostType":2,"repost":{"id":"2182094779","pubTimestamp":1636723680,"share":"https://www.laohu8.com/m/news/2182094779?lang=&edition=full","pubTime":"2021-11-12 21:28","market":"us","language":"en","title":"The Smartest Stocks to Buy With $20 Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2182094779","media":"Motley Fool","summary":"A small amount of money can go a long way when invested in these top-notch stocks.","content":"<p>Time and again, Wall Street has shown investors the power of patience.</p>\n<p>Over the past 71 years, the broad-based <b>S&amp;P 500</b> has undergone 38 double-digit percentage corrections. Despite the regularity of these moves lower, every crash and correction throughout this period was eventually erased by a bull market rally. To put things succinctly, if investors buy great companies and allow their investment theses to play out over long periods of time, their chances of building wealth is very high.</p>\n<p>Best of all, with most online brokerages discarding minimum deposit requirements and commission fees, investors can begin or further their trek to financial independence with any amount of cash -- even $20. If you have $20 ready to put to work in the market, and it won't be needed to cover bills or other essential costs, the following trio of companies are the smartest stocks to buy right now.</p>\n<h2>Exelixis</h2>\n<p>One of the savviest stocks patient investors can buy right now with $20 is cancer-drug developer <b>Exelixis</b> (NASDAQ:EXEL).</p>\n<p>Last week, Exelixis announced its third-quarter operating results, which failed to hit the mark and sent its shares down by more than 10%. Sales of lead-drug Cabometyx were shy of Wall Street's expectations, which caused Exelixis to lower the upper end of its full-year sales outlook. Generally, lowering sales expectations will be met with frowns on Wall Street.</p>\n<p>However, this short-term weakness should be viewed as an opportunity, especially with the company's price-to-earnings-growth ratio (PEG ratio) below 0.4. A PEG ratio below 1 is typically considered \"undervalued.\"</p>\n<p>Although the landscape for first-line advanced renal cell carcinoma (RCC) is competitive, Cabometyx has demonstrated the ability to grow sales by a sustained double-digit percentage in RCC and advanced hepatocellular carcinoma. On an annual run-rate basis, Cabometyx is pacing more than $1 billion in sales -- and it's not done growing.</p>\n<p>More importantly, Exelixis' lead drug is being examined in close to six dozen clinical trials as a monotherapy or combination treatment. If even a handful of these trials yield a positive result, label-expansion opportunities and organic growth could send Cabometyx to north of $2 billion in peak annual sales.</p>\n<p>Additionally, Exelixis' robust cash position ($1.8 billion in cash, cash equivalents, and restricted cash) and healthy operating cash flow have allowed it to reignite its internal research engine. This includes advancing internally developed compounds into phase 1 studies, as well as signing collaboration agreements to potentially expand its cancer-drug pipeline.</p>\n<p>It's not often you can marry growth and value with the same company, but that's exactly what investors can do with biotech stock Exelixis.</p>\n<h2>Jushi Holdings</h2>\n<p>Some of the most deeply discounted growth stocks can be found in the marijuana industry, which is why U.S. multi-state operator (MSO) <b>Jushi Holdings</b> (OTC:JUSHF) makes for a smart buy with $20.</p>\n<p>To start with, don't be concerned about a lack of cannabis reform in Washington. While life would undoubtedly be easier for pot stocks if lawmakers would simply follow the overwhelming will of the public and legalize cannabis, allowing individual states to legalize and regulate their pot industries is working fine. Thus far, 36 states have given the green light to weed in some capacity, which is providing growth opportunities for MSOs like Jushi.</p>\n<p>In relative terms, Jushi is a small fry, with only 26 operating dispensaries at the moment. Comparatively, a handful of MSOs have in the neighborhood of (or more than) 100 open locations. But Jushi isn't about reckless expansion. Its management team favors methodical expansion in core markets. For Jushi, these core states are Pennsylvania, Illinois, and Virginia.</p>\n<p>The reason management has chosen these states is due to their billion-dollar sales potential (Illinois hit $1 billion in legal pot revenue in 2020) and their limited-license status. In limited-license cannabis markets, regulators purposely limit how many dispensary licenses are issued in total, as well as to a single business. For a smaller player like Jushi, this competitive protection ensures it'll have a fair shot to build up its brand(s) and garner a loyal following in these core markets.</p>\n<p>Something else impressive about Jushi, and <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the reasons I plan to be a long-term shareholder, is the participation of management and insiders. Of the first $250 million raised by the company, $45 million came from insiders and execs. When leadership has skin in the game right alongside their investors, good things tend to happen.</p>\n<p>Jushi is expected to turn the corner to recurring profitability in 2022 and the company's growing sales faster than virtually all other MSOs. The company checks all the appropriate boxes for growth investors.</p>\n<h2>Viatris</h2>\n<p>On the other hand, if value runs through your blood, generic-drug giant <b>Viatris</b> (NASDAQ:VTRS) is one of the smartest stocks you can buy right now with $20.</p>\n<p>Roughly a year ago, Viatris was born from the combination of <b>Pfizer</b>'s established drug unit Upjohn with generic-drug developer Mylan. Due to generic-drug price weakness throughout the industry, the company's first year as a public company has been one to forget. However, this near-term underperformance represents the perfect opportunity for patient investors to nab an exceptionally inexpensive and profitable drug stock.</p>\n<p>There were a number of reasons Upjohn and Mylan tied the knot. First off, there were clear-cut cost synergies. The company expects to recognize more than $500 million in cost synergies this year, with well over $1 billion in annual cost reductions by 2023.</p>\n<p>As a combined company, Viatris is also in a better position to tackle its outstanding debt. Through the first six months of 2021, $1.15 billion in debt was repaid. By the end of 2023, $6.5 billion in debt should be repaid, which represents a quarter of the company's combined debt ($26 billion), as of November 2020.</p>\n<p>Beyond just trimming the fat, Viatris should be able to kick-start its internal drug research in 2024 once debt levels are reduced to more favorable levels. Keep in mind that new drug research would come atop existing biosimilar clinical trials, which are expected to generate billions of dollars in future sales.</p>\n<p>Viatris won't deliver jaw-dropping growth like Jushi, or even double-digit annual sales upside like Exelixis. But with a steadiness to generic-drug demand and an improving balance sheet, Viatris' forward price-to-earnings ratio below 4 simply doesn't do its stock justice.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Smartest Stocks to Buy With $20 Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Smartest Stocks to Buy With $20 Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-12 21:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/12/the-smartest-stocks-to-buy-with-20-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Time and again, Wall Street has shown investors the power of patience.\nOver the past 71 years, the broad-based S&P 500 has undergone 38 double-digit percentage corrections. Despite the regularity of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/12/the-smartest-stocks-to-buy-with-20-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"EXEL":"伊克力西斯","VTRS":"Viatris Inc.","JUSHF":"Jushi Holdings Inc."},"source_url":"https://www.fool.com/investing/2021/11/12/the-smartest-stocks-to-buy-with-20-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2182094779","content_text":"Time and again, Wall Street has shown investors the power of patience.\nOver the past 71 years, the broad-based S&P 500 has undergone 38 double-digit percentage corrections. Despite the regularity of these moves lower, every crash and correction throughout this period was eventually erased by a bull market rally. To put things succinctly, if investors buy great companies and allow their investment theses to play out over long periods of time, their chances of building wealth is very high.\nBest of all, with most online brokerages discarding minimum deposit requirements and commission fees, investors can begin or further their trek to financial independence with any amount of cash -- even $20. If you have $20 ready to put to work in the market, and it won't be needed to cover bills or other essential costs, the following trio of companies are the smartest stocks to buy right now.\nExelixis\nOne of the savviest stocks patient investors can buy right now with $20 is cancer-drug developer Exelixis (NASDAQ:EXEL).\nLast week, Exelixis announced its third-quarter operating results, which failed to hit the mark and sent its shares down by more than 10%. Sales of lead-drug Cabometyx were shy of Wall Street's expectations, which caused Exelixis to lower the upper end of its full-year sales outlook. Generally, lowering sales expectations will be met with frowns on Wall Street.\nHowever, this short-term weakness should be viewed as an opportunity, especially with the company's price-to-earnings-growth ratio (PEG ratio) below 0.4. A PEG ratio below 1 is typically considered \"undervalued.\"\nAlthough the landscape for first-line advanced renal cell carcinoma (RCC) is competitive, Cabometyx has demonstrated the ability to grow sales by a sustained double-digit percentage in RCC and advanced hepatocellular carcinoma. On an annual run-rate basis, Cabometyx is pacing more than $1 billion in sales -- and it's not done growing.\nMore importantly, Exelixis' lead drug is being examined in close to six dozen clinical trials as a monotherapy or combination treatment. If even a handful of these trials yield a positive result, label-expansion opportunities and organic growth could send Cabometyx to north of $2 billion in peak annual sales.\nAdditionally, Exelixis' robust cash position ($1.8 billion in cash, cash equivalents, and restricted cash) and healthy operating cash flow have allowed it to reignite its internal research engine. This includes advancing internally developed compounds into phase 1 studies, as well as signing collaboration agreements to potentially expand its cancer-drug pipeline.\nIt's not often you can marry growth and value with the same company, but that's exactly what investors can do with biotech stock Exelixis.\nJushi Holdings\nSome of the most deeply discounted growth stocks can be found in the marijuana industry, which is why U.S. multi-state operator (MSO) Jushi Holdings (OTC:JUSHF) makes for a smart buy with $20.\nTo start with, don't be concerned about a lack of cannabis reform in Washington. While life would undoubtedly be easier for pot stocks if lawmakers would simply follow the overwhelming will of the public and legalize cannabis, allowing individual states to legalize and regulate their pot industries is working fine. Thus far, 36 states have given the green light to weed in some capacity, which is providing growth opportunities for MSOs like Jushi.\nIn relative terms, Jushi is a small fry, with only 26 operating dispensaries at the moment. Comparatively, a handful of MSOs have in the neighborhood of (or more than) 100 open locations. But Jushi isn't about reckless expansion. Its management team favors methodical expansion in core markets. For Jushi, these core states are Pennsylvania, Illinois, and Virginia.\nThe reason management has chosen these states is due to their billion-dollar sales potential (Illinois hit $1 billion in legal pot revenue in 2020) and their limited-license status. In limited-license cannabis markets, regulators purposely limit how many dispensary licenses are issued in total, as well as to a single business. For a smaller player like Jushi, this competitive protection ensures it'll have a fair shot to build up its brand(s) and garner a loyal following in these core markets.\nSomething else impressive about Jushi, and one of the reasons I plan to be a long-term shareholder, is the participation of management and insiders. Of the first $250 million raised by the company, $45 million came from insiders and execs. When leadership has skin in the game right alongside their investors, good things tend to happen.\nJushi is expected to turn the corner to recurring profitability in 2022 and the company's growing sales faster than virtually all other MSOs. The company checks all the appropriate boxes for growth investors.\nViatris\nOn the other hand, if value runs through your blood, generic-drug giant Viatris (NASDAQ:VTRS) is one of the smartest stocks you can buy right now with $20.\nRoughly a year ago, Viatris was born from the combination of Pfizer's established drug unit Upjohn with generic-drug developer Mylan. Due to generic-drug price weakness throughout the industry, the company's first year as a public company has been one to forget. However, this near-term underperformance represents the perfect opportunity for patient investors to nab an exceptionally inexpensive and profitable drug stock.\nThere were a number of reasons Upjohn and Mylan tied the knot. First off, there were clear-cut cost synergies. The company expects to recognize more than $500 million in cost synergies this year, with well over $1 billion in annual cost reductions by 2023.\nAs a combined company, Viatris is also in a better position to tackle its outstanding debt. Through the first six months of 2021, $1.15 billion in debt was repaid. By the end of 2023, $6.5 billion in debt should be repaid, which represents a quarter of the company's combined debt ($26 billion), as of November 2020.\nBeyond just trimming the fat, Viatris should be able to kick-start its internal drug research in 2024 once debt levels are reduced to more favorable levels. Keep in mind that new drug research would come atop existing biosimilar clinical trials, which are expected to generate billions of dollars in future sales.\nViatris won't deliver jaw-dropping growth like Jushi, or even double-digit annual sales upside like Exelixis. But with a steadiness to generic-drug demand and an improving balance sheet, Viatris' forward price-to-earnings ratio below 4 simply doesn't do its stock justice.","news_type":1},"isVote":1,"tweetType":1,"viewCount":618,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":852098147,"gmtCreate":1635220106862,"gmtModify":1635220107062,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Tesla for the win","listText":"Tesla for the win","text":"Tesla for the win","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/852098147","repostId":"2178471618","repostType":4,"isVote":1,"tweetType":1,"viewCount":524,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":824103123,"gmtCreate":1634285830465,"gmtModify":1634285830574,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Not every earnings season is the&nbsp;same, and most forecast dun run true","listText":"Not every earnings season is the&nbsp;same, and most forecast dun run true","text":"Not every earnings season is the same, and most forecast dun run true","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/824103123","repostId":"1123139232","repostType":4,"repost":{"id":"1123139232","pubTimestamp":1634284219,"share":"https://www.laohu8.com/m/news/1123139232?lang=&edition=full","pubTime":"2021-10-15 15:50","market":"us","language":"en","title":"This Earnings Season Was Supposed to Be Terrible. It’s Turning Out Pretty Good.","url":"https://stock-news.laohu8.com/highlight/detail?id=1123139232","media":"Barrons","summary":"Earnings are beating estimates, stocks are soaring, and analysts are quickly raising numbers.\nThe ag","content":"<p></p>\n<p>Earnings are beating estimates, stocks are soaring, and analysts are quickly raising numbers.</p>\n<p>The aggregate earnings per share result on the S&amp;P 500 had beaten estimates by 11.7% coming into Thursday, according to Credit Suisse. Almost three quarters of companies reporting so far have posted better-then-expected numbers.</p>\n<p>The surprisingly robust profits underscore that analysts still are getting a handle on the economy as it continues to recover from the Covid-19 pandemic. A year ago, many companies were being ravaged by lockdowns.</p>\n<p>Now many are seeing surging revenue and net income. Sales and EPS on the S&amp;P 500 this quarter are currently expected to rise about 14% and 26% year-over-year, respectively.</p>\n<p>Earnings this quarter weren’t supposed to be this good. The market was expecting lesser earnings beats, just 4% above estimates as recently as Tuesday. After all, analysts have already revised earnings estimates up significantly&nbsp;this year, as companies were beating by more than 15% earlier in the year. Plus, supply chain constraints and labor shortages are bringing costs higher for companies.</p>\n<p>To be sure, a big reason earnings are outperforming are the financials, which had beaten estimates by 22% into Thursday.Banks have posted impressive results all week. Still, even excluding financials, S&amp;P 500 companies were beating profit forecasts by about 5% as of Thursday morning.</p>\n<p>Share prices are being lifted by the earnings beats.Citigroup&nbsp;(C), Morgan Stanley (MS) and&nbsp;Bank of America&nbsp;(BAC) were all up between 0.7% and 4.5% after earnings, as these banks freed up billions of dollars each that had previously been reserved to absorb potential loan losses. Elsewhere, Domino’s Pizza (DPZ) and&nbsp;Walgreens Boots Alliance&nbsp;(WBA) beat profit expectations, with their stocks rising 0.6% and 7.4%, respectively.Fastenal&nbsp;(FAST) beat estimates and saw its stock rise 3% after earnings. Key to its story: Analysts said the company raised prices enough&nbsp;to offset higher transportation and product costs.</p>\n<p>It isn’t just companies reporting earnings that investors are rewarding — the broader market is slipping into relief-rally mode. The S&amp;P 500 rose 1.7%. While less than a tenth of companies on the index will have reported by the end of this week, more than 90% of its stocks were rallying Thursday, according to FactSet. Investors seem to be anticipating that earnings will be stronger for companies that haven’t reported yet.</p>\n<p>Going forward, investors will still have to keep a close eye on profit margins. Supply and labor limitations are still a concern — and not every company is like Fastenal. “The focus remains on margin sustainability in this era of rapidly-rising costs,” writes Christopher Harvey, head of equity strategy at Wells Fargo.</p>\n<p>The point is that earnings look fine — so far.</p>\n<p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Earnings Season Was Supposed to Be Terrible. It’s Turning Out Pretty Good.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Earnings Season Was Supposed to Be Terrible. It’s Turning Out Pretty Good.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-15 15:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-earnings-season-was-supposed-to-be-terrible-its-turning-out-pretty-good-51634242091?mod=hp_LEAD_1><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Earnings are beating estimates, stocks are soaring, and analysts are quickly raising numbers.\nThe aggregate earnings per share result on the S&P 500 had beaten estimates by 11.7% coming into Thursday,...</p>\n\n<a href=\"https://www.barrons.com/articles/this-earnings-season-was-supposed-to-be-terrible-its-turning-out-pretty-good-51634242091?mod=hp_LEAD_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.barrons.com/articles/this-earnings-season-was-supposed-to-be-terrible-its-turning-out-pretty-good-51634242091?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123139232","content_text":"Earnings are beating estimates, stocks are soaring, and analysts are quickly raising numbers.\nThe aggregate earnings per share result on the S&P 500 had beaten estimates by 11.7% coming into Thursday, according to Credit Suisse. Almost three quarters of companies reporting so far have posted better-then-expected numbers.\nThe surprisingly robust profits underscore that analysts still are getting a handle on the economy as it continues to recover from the Covid-19 pandemic. A year ago, many companies were being ravaged by lockdowns.\nNow many are seeing surging revenue and net income. Sales and EPS on the S&P 500 this quarter are currently expected to rise about 14% and 26% year-over-year, respectively.\nEarnings this quarter weren’t supposed to be this good. The market was expecting lesser earnings beats, just 4% above estimates as recently as Tuesday. After all, analysts have already revised earnings estimates up significantly this year, as companies were beating by more than 15% earlier in the year. Plus, supply chain constraints and labor shortages are bringing costs higher for companies.\nTo be sure, a big reason earnings are outperforming are the financials, which had beaten estimates by 22% into Thursday.Banks have posted impressive results all week. Still, even excluding financials, S&P 500 companies were beating profit forecasts by about 5% as of Thursday morning.\nShare prices are being lifted by the earnings beats.Citigroup (C), Morgan Stanley (MS) and Bank of America (BAC) were all up between 0.7% and 4.5% after earnings, as these banks freed up billions of dollars each that had previously been reserved to absorb potential loan losses. Elsewhere, Domino’s Pizza (DPZ) and Walgreens Boots Alliance (WBA) beat profit expectations, with their stocks rising 0.6% and 7.4%, respectively.Fastenal (FAST) beat estimates and saw its stock rise 3% after earnings. Key to its story: Analysts said the company raised prices enough to offset higher transportation and product costs.\nIt isn’t just companies reporting earnings that investors are rewarding — the broader market is slipping into relief-rally mode. The S&P 500 rose 1.7%. While less than a tenth of companies on the index will have reported by the end of this week, more than 90% of its stocks were rallying Thursday, according to FactSet. Investors seem to be anticipating that earnings will be stronger for companies that haven’t reported yet.\nGoing forward, investors will still have to keep a close eye on profit margins. Supply and labor limitations are still a concern — and not every company is like Fastenal. “The focus remains on margin sustainability in this era of rapidly-rising costs,” writes Christopher Harvey, head of equity strategy at Wells Fargo.\nThe point is that earnings look fine — so far.","news_type":1},"isVote":1,"tweetType":1,"viewCount":562,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829759350,"gmtCreate":1633561143304,"gmtModify":1633561143508,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"True investors would have a tough mentality and are able to ride out market volatility. The weaker ones would sell at a loss and suffer","listText":"True investors would have a tough mentality and are able to ride out market volatility. The weaker ones would sell at a loss and suffer","text":"True investors would have a tough mentality and are able to ride out market volatility. The weaker ones would sell at a loss and suffer","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/829759350","repostId":"2173917919","repostType":4,"repost":{"id":"2173917919","pubTimestamp":1633524180,"share":"https://www.laohu8.com/m/news/2173917919?lang=&edition=full","pubTime":"2021-10-06 20:43","market":"us","language":"en","title":"Stocks Set to Fall Again: Is This the Secret to Making Money When Markets Plunge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2173917919","media":"Motley Fool","summary":"A certain type of investment is on the rise Wednesday morning.","content":"<p>Wall Street has been extremely turbulent lately, and on Wednesday morning, investors got another case of the jitters. Focusing on all the things that could go wrong in the market, major stock indexes were poised to lose substantial ground when the market opens. In premarket trading Wednesday morning as of 8 a.m. EDT, futures on the <b>Dow Jones Industrial Average </b>(DJINDICES:^DJI) were down 326 points to 33,857. Futures on the <b>S&amp;P 500 </b>(SNPINDEX:^GSPC) dropped 48 points to 4,286, and <b>Nasdaq Composite </b>(NASDAQINDEX:^IXIC) futures fell 186 points to 14,470.</p>\n<p>Stock market volatility levels have been on the rise, and many investors are looking to protect themselves against further declines by looking to the options market. A key measure of volatility, the <b>CBOE Volatility Index </b>(VOLATILITYINDICES:^VIX), has seen a couple of its biggest spikes all year come in the last couple of weeks. That has some investors looking for ways to profit -- and this morning, they're turning to exchange-traded funds designed to try to track the VIX.</p>\n<p><img src=\"https://static.tigerbbs.com/22719786dce6b2278c6f4132a5bc86ff\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Volatility ETFs and the VIX</h3>\n<p>The ETF universe has found ways to invest in nearly anything, and volatility is no exception. Because there's no way to invest directly in movements in the VIX, volatility ETFs concentrate on VIX futures contracts.</p>\n<p>One relatively simple exchange-traded volatility product is <b>iPath Series B S&amp;P 500 VIX Short-Term Futures </b>(NYSEMKT:VXX). This security is designed to track the daily movements in the front month and second month VIX futures contracts. Given this morning's rise in anticipated volatility, shares of the iPath volatility product are up more than 4% in pre-market trading.</p>\n<p>A similar product is <b>ProShares VIX Short-Term Futures ETF </b>(NYSEMKT:VIXY). It uses a slightly different methodology in selecting futures contracts to achieve the same goal. It's also up nearly 4% as of 8 a.m. EDT Wednesday.</p>\n<p>Those investors seeking an even larger gain from rising volatility levels can use leveraged volatility ETFs. The <b>ProShares Ultra VIX Short-Term Futures ETF </b>(NYSEMKT:UVXY) offers moves that are 1.5 times the corresponding daily movement of various VIX futures contracts. That multiple has the ProShares fund up nearly 6% in the pre-market session Wednesday.</p>\n<h3>The dangers of volatility ETFs</h3>\n<p>Investing in volatility is dangerous. The first thing to keep in mind is that these products are all designed to tie to <i>daily </i>returns, and that makes them less than ideal for long-term investors. For instance, looking at the iPath's history, it lost money every single year from 2009 to 2017, eked out a tiny positive return in 2018, lost two-thirds of its value in 2019, and climbed just 11% in 2020's turbulent stock market year. It's down more than 60% so far in 2021.</p>\n<p>However, the massive returns you can earn if you have perfect timing are tempting. From mid-February to mid-March in 2020, the iPath product jumped more than 320%. The ProShares Ultra volatility ETF gained nearly 700%. But you do have to have perfect timing on both ends -- by the end of April 2020, the funds had given back 50% to 60% of those gains. By the end of the year, the ProShares fund had actually dropped back to a net loss after its huge spike.</p>\n<p>Because of their big daily moves, volatility ETFs are attractive to short-term traders. For long-term investors, though, the better way to play volatility is to have cash on hand to buy attractive stocks when they're cheap after a downswing. The bargains you'll reap can end up being top performers in your portfolio.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks Set to Fall Again: Is This the Secret to Making Money When Markets Plunge?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks Set to Fall Again: Is This the Secret to Making Money When Markets Plunge?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-06 20:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/06/stocks-fall-again-secret-make-money-market-plunge/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Wall Street has been extremely turbulent lately, and on Wednesday morning, investors got another case of the jitters. Focusing on all the things that could go wrong in the market, major stock indexes ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/06/stocks-fall-again-secret-make-money-market-plunge/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UVXY":"1.5倍做多波动率指数短期期货ETF-ProShares","VIXY":"波动率短期期货指数ETF","VXX":"短期VIX期货ETN","SVXY":"0.5倍做空波动率指数短期期货ETF","TVIX":"二倍做多VIX波动率指数短期期权ETN"},"source_url":"https://www.fool.com/investing/2021/10/06/stocks-fall-again-secret-make-money-market-plunge/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2173917919","content_text":"Wall Street has been extremely turbulent lately, and on Wednesday morning, investors got another case of the jitters. Focusing on all the things that could go wrong in the market, major stock indexes were poised to lose substantial ground when the market opens. In premarket trading Wednesday morning as of 8 a.m. EDT, futures on the Dow Jones Industrial Average (DJINDICES:^DJI) were down 326 points to 33,857. Futures on the S&P 500 (SNPINDEX:^GSPC) dropped 48 points to 4,286, and Nasdaq Composite (NASDAQINDEX:^IXIC) futures fell 186 points to 14,470.\nStock market volatility levels have been on the rise, and many investors are looking to protect themselves against further declines by looking to the options market. A key measure of volatility, the CBOE Volatility Index (VOLATILITYINDICES:^VIX), has seen a couple of its biggest spikes all year come in the last couple of weeks. That has some investors looking for ways to profit -- and this morning, they're turning to exchange-traded funds designed to try to track the VIX.\n\nImage source: Getty Images.\nVolatility ETFs and the VIX\nThe ETF universe has found ways to invest in nearly anything, and volatility is no exception. Because there's no way to invest directly in movements in the VIX, volatility ETFs concentrate on VIX futures contracts.\nOne relatively simple exchange-traded volatility product is iPath Series B S&P 500 VIX Short-Term Futures (NYSEMKT:VXX). This security is designed to track the daily movements in the front month and second month VIX futures contracts. Given this morning's rise in anticipated volatility, shares of the iPath volatility product are up more than 4% in pre-market trading.\nA similar product is ProShares VIX Short-Term Futures ETF (NYSEMKT:VIXY). It uses a slightly different methodology in selecting futures contracts to achieve the same goal. It's also up nearly 4% as of 8 a.m. EDT Wednesday.\nThose investors seeking an even larger gain from rising volatility levels can use leveraged volatility ETFs. The ProShares Ultra VIX Short-Term Futures ETF (NYSEMKT:UVXY) offers moves that are 1.5 times the corresponding daily movement of various VIX futures contracts. That multiple has the ProShares fund up nearly 6% in the pre-market session Wednesday.\nThe dangers of volatility ETFs\nInvesting in volatility is dangerous. The first thing to keep in mind is that these products are all designed to tie to daily returns, and that makes them less than ideal for long-term investors. For instance, looking at the iPath's history, it lost money every single year from 2009 to 2017, eked out a tiny positive return in 2018, lost two-thirds of its value in 2019, and climbed just 11% in 2020's turbulent stock market year. It's down more than 60% so far in 2021.\nHowever, the massive returns you can earn if you have perfect timing are tempting. From mid-February to mid-March in 2020, the iPath product jumped more than 320%. The ProShares Ultra volatility ETF gained nearly 700%. But you do have to have perfect timing on both ends -- by the end of April 2020, the funds had given back 50% to 60% of those gains. By the end of the year, the ProShares fund had actually dropped back to a net loss after its huge spike.\nBecause of their big daily moves, volatility ETFs are attractive to short-term traders. For long-term investors, though, the better way to play volatility is to have cash on hand to buy attractive stocks when they're cheap after a downswing. The bargains you'll reap can end up being top performers in your portfolio.","news_type":1},"isVote":1,"tweetType":1,"viewCount":484,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829323220,"gmtCreate":1633475890050,"gmtModify":1633475955035,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"$PLTR oh yeah!!","listText":"$PLTR oh yeah!!","text":"$PLTR oh yeah!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/829323220","repostId":"1194519706","repostType":4,"isVote":1,"tweetType":1,"viewCount":345,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865402199,"gmtCreate":1633008831674,"gmtModify":1633008831859,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Well, a good read","listText":"Well, a good read","text":"Well, a good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865402199","repostId":"2171986054","repostType":4,"repost":{"id":"2171986054","pubTimestamp":1632973200,"share":"https://www.laohu8.com/m/news/2171986054?lang=&edition=full","pubTime":"2021-09-30 11:40","market":"us","language":"en","title":"3 Vanguard ETFs I'm Buying if the Stock Market Crashes","url":"https://stock-news.laohu8.com/highlight/detail?id=2171986054","media":"Motley Fool","summary":"Nobody knows whether the market will crash. But if it does, I'm stocking up on these investments.","content":"<blockquote>\n <b>Nobody knows whether the market will crash. But if it does, I'm stocking up on these investments.</b>\n</blockquote>\n<p><b>Key Points</b></p>\n<ul>\n <li>The Vanguard S&amp;P 500 ETF can be a great option for withstanding market volatility.</li>\n <li>The Vanguard Total Stock Market ETF can help reduce your risk.</li>\n <li>The Vanguard Growth ETF can supercharge your investments.</li>\n</ul>\n<p>Over the past year and a half, the stock market has experienced <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the greatest growth streaks in history. The <b>S&amp;P 500</b> is up nearly 100% since March 2020, and investors have seen their portfolios skyrocket during that time.</p>\n<p>Some experts believe, however, that it's only a matter of time before prices fall. Market downturns may be intimidating, but they're normal. In fact, it's healthy for the market to experience corrections every so often, because stock prices can't continue climbing forever.</p>\n<p>Nobody knows for sure whether a crash is on the horizon, or, if it does happen, how significant it will be. However, if the market does take a turn for the worse, there are a few exchange-traded funds (ETFs) I'll be buying.</p>\n<p><img src=\"https://static.tigerbbs.com/9c5cb96961b54db9d77a960894b88df7\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>1. Vanguard S&amp;P 500 ETF (VOO)</h3>\n<p>It may seem counterintuitive to buy when the market is down, but crashes can be a fantastic opportunity to invest when prices are lower. ETFs trade like stocks, so when the market is down, their share prices are typically lower as well.</p>\n<p>One ETF I'm planning to invest in heavily if the market crashes is the <b>Vanguard S&amp;P 500 ETF</b> (NYSEMKT:VOO). Like its name suggests, this fund tracks the S&amp;P 500 and includes all the stocks within the index itself.</p>\n<p>The S&amp;P 500 ETF is one of the most dependable investments out there. Historically, the index itself has faced countless crashes and corrections, and it has recovered from each and every one. If the market crashes again, there's a very good chance this ETF will be able to bounce back. And by buying when prices are lower, you'll reap the rewards once the market recovers and prices increase once again.</p>\n<h3>2. Vanguard Total Stock Market ETF (VTI)</h3>\n<p>The <b>Vanguard Total Stock Market ETF</b> (NYSEMKT:VTI) is similar to the S&amp;P 500 ETF, but it includes more stocks from more diverse companies.</p>\n<p>The S&amp;P 500 ETF includes stocks from 500 large companies, while the Total Stock Market ETF includes nearly 4,000 stocks from small, midsize, and large corporations. This provides greater diversification and can decrease your risk.</p>\n<p>Another advantage of this fund is that it's designed to follow the market as a whole. Again, the stock market has a strong track record when it comes to recovering from downturns, so by investing in this ETF, it's likely your investments will recover as well.</p>\n<h3>3. Vanguard Growth ETF (VUG)</h3>\n<p>The <b>Vanguard Growth ETF</b> (NYSEMKT:VUG) includes 285 stocks from companies that are expected to grow at a faster-than-average pace.</p>\n<p>This fund includes the fewest holdings of the three ETFs on the list, which does make it slightly riskier. However, many of the biggest stocks in the fund are from behemoth tech corporations like <b>Amazon</b>, <b>Apple</b>, and <b>Microsoft</b> -- companies that are very likely to survive market volatility.</p>\n<p>One of the primary advantages of growth ETFs is that they're designed to earn above-average returns. This particular ETF has earned an average rate of return of around 12% per year since its inception, for example. By comparison, the S&amp;P 500 has historically earned a 10% average annual return, and the Vanguard Total Stock Market ETF has earned an average return of around 9% per year.</p>\n<p>Investing in ETFs can be a fantastic way to build wealth with less effort, and buying during a market downturn can make investing more affordable. While nobody knows for certain whether a market crash is coming, by making a list now of the investments you want to buy, you can snag them at a discount later.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Vanguard ETFs I'm Buying if the Stock Market Crashes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Vanguard ETFs I'm Buying if the Stock Market Crashes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-30 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/29/3-vanguard-etfs-buy-if-the-stock-market-crashes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nobody knows whether the market will crash. But if it does, I'm stocking up on these investments.\n\nKey Points\n\nThe Vanguard S&P 500 ETF can be a great option for withstanding market volatility.\nThe ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/29/3-vanguard-etfs-buy-if-the-stock-market-crashes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SSO":"两倍做多标普500ETF",".SPX":"S&P 500 Index","OEX":"标普100","IVV":"标普500指数ETF","VUG":"成长股指数ETF-Vanguard MSCI","UPRO":"三倍做多标普500ETF","SPY":"标普500ETF","OEF":"标普100指数ETF-iShares","SH":"标普500反向ETF","SPXU":"三倍做空标普500ETF","VOO":"Vanguard标普500ETF","VTI":"大盘指数ETF-Vanguard MSCI","SDS":"两倍做空标普500ETF"},"source_url":"https://www.fool.com/investing/2021/09/29/3-vanguard-etfs-buy-if-the-stock-market-crashes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2171986054","content_text":"Nobody knows whether the market will crash. But if it does, I'm stocking up on these investments.\n\nKey Points\n\nThe Vanguard S&P 500 ETF can be a great option for withstanding market volatility.\nThe Vanguard Total Stock Market ETF can help reduce your risk.\nThe Vanguard Growth ETF can supercharge your investments.\n\nOver the past year and a half, the stock market has experienced one of the greatest growth streaks in history. The S&P 500 is up nearly 100% since March 2020, and investors have seen their portfolios skyrocket during that time.\nSome experts believe, however, that it's only a matter of time before prices fall. Market downturns may be intimidating, but they're normal. In fact, it's healthy for the market to experience corrections every so often, because stock prices can't continue climbing forever.\nNobody knows for sure whether a crash is on the horizon, or, if it does happen, how significant it will be. However, if the market does take a turn for the worse, there are a few exchange-traded funds (ETFs) I'll be buying.\n\nImage source: Getty Images.\n1. Vanguard S&P 500 ETF (VOO)\nIt may seem counterintuitive to buy when the market is down, but crashes can be a fantastic opportunity to invest when prices are lower. ETFs trade like stocks, so when the market is down, their share prices are typically lower as well.\nOne ETF I'm planning to invest in heavily if the market crashes is the Vanguard S&P 500 ETF (NYSEMKT:VOO). Like its name suggests, this fund tracks the S&P 500 and includes all the stocks within the index itself.\nThe S&P 500 ETF is one of the most dependable investments out there. Historically, the index itself has faced countless crashes and corrections, and it has recovered from each and every one. If the market crashes again, there's a very good chance this ETF will be able to bounce back. And by buying when prices are lower, you'll reap the rewards once the market recovers and prices increase once again.\n2. Vanguard Total Stock Market ETF (VTI)\nThe Vanguard Total Stock Market ETF (NYSEMKT:VTI) is similar to the S&P 500 ETF, but it includes more stocks from more diverse companies.\nThe S&P 500 ETF includes stocks from 500 large companies, while the Total Stock Market ETF includes nearly 4,000 stocks from small, midsize, and large corporations. This provides greater diversification and can decrease your risk.\nAnother advantage of this fund is that it's designed to follow the market as a whole. Again, the stock market has a strong track record when it comes to recovering from downturns, so by investing in this ETF, it's likely your investments will recover as well.\n3. Vanguard Growth ETF (VUG)\nThe Vanguard Growth ETF (NYSEMKT:VUG) includes 285 stocks from companies that are expected to grow at a faster-than-average pace.\nThis fund includes the fewest holdings of the three ETFs on the list, which does make it slightly riskier. However, many of the biggest stocks in the fund are from behemoth tech corporations like Amazon, Apple, and Microsoft -- companies that are very likely to survive market volatility.\nOne of the primary advantages of growth ETFs is that they're designed to earn above-average returns. This particular ETF has earned an average rate of return of around 12% per year since its inception, for example. By comparison, the S&P 500 has historically earned a 10% average annual return, and the Vanguard Total Stock Market ETF has earned an average return of around 9% per year.\nInvesting in ETFs can be a fantastic way to build wealth with less effort, and buying during a market downturn can make investing more affordable. While nobody knows for certain whether a market crash is coming, by making a list now of the investments you want to buy, you can snag them at a discount later.","news_type":1},"isVote":1,"tweetType":1,"viewCount":451,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865406495,"gmtCreate":1633008797466,"gmtModify":1633008798660,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Oh yeahhh","listText":"Oh yeahhh","text":"Oh yeahhh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865406495","repostId":"1190243332","repostType":4,"isVote":1,"tweetType":1,"viewCount":530,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866288127,"gmtCreate":1632785111769,"gmtModify":1632797903233,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Aaple Ftw!","listText":"Aaple Ftw!","text":"Aaple Ftw!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/866288127","repostId":"1143344359","repostType":4,"isVote":1,"tweetType":1,"viewCount":655,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866077583,"gmtCreate":1632717194842,"gmtModify":1632798328162,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Duolingo is worth a look","listText":"Duolingo is worth a look","text":"Duolingo is worth a look","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/866077583","repostId":"2170108956","repostType":4,"repost":{"id":"2170108956","pubTimestamp":1632715020,"share":"https://www.laohu8.com/m/news/2170108956?lang=&edition=full","pubTime":"2021-09-27 11:57","market":"us","language":"en","title":"3 Stocks We're Ready to Buy if the Market Crashes This Month","url":"https://stock-news.laohu8.com/highlight/detail?id=2170108956","media":"Motley Fool","summary":"These tech stocks are riding secular growth trends, but would be especially good buys if there's a market pullback.","content":"<blockquote>\n <b>These tech stocks are riding secular growth trends, but would be especially good buys if there's a market pullback.</b>\n</blockquote>\n<p><b>Key Points</b></p>\n<ul>\n <li>Marvell Technology Group has transformed itself into a top data center supplier.</li>\n <li>Duolingo is a language app, but it has big education aspirations.</li>\n <li>Apple still has a big opportunity in China despite the recent troubles there.</li>\n</ul>\n<p>Historically, the stock market crashes an average of once almost every two years (with a crash defined as a decline of 10% from highs). Stocks overall haven't suffered such a setback since the pandemic started a year and a half ago, so many investors worry that a 10% pullback is imminent.</p>\n<p>The historical average is just that, though: an average. There's no telling when the market will crash and what will ultimately cause it to temporarily fall in value. But a focus on quality companies riding economic growth trends will set you up for long-term success no matter what the stock market does. Three Fool.com contributors think <b>Marvell Technology Group </b>(NASDAQ:MRVL), <b>Duolingo </b>(NASDAQ:DUOL), and <b>Apple </b>(NASDAQ:AAPL) are great buys right now, and would be especially great pickups if the market falls in the next month.</p>\n<h3>Doubling down on data center hardware</h3>\n<p><b>Nicholas Rossolillo (Marvell Technology Group): </b>Semiconductor designer Marvell is flying high this year -- and not just because of the global chip shortage. The company has made four major acquisitions since 2018, and a fifth <a href=\"https://laohu8.com/S/AONE.U\">one</a> is currently pending. These takeovers have transformed Marvell's operations, reducing its reliance on consumer electronics and upping its game in data centers and 5G mobile networks.</p>\n<p>In fact, Marvell said on its last earnings call that data center sales (40% of revenue) are poised to grow for years to come. Marvell's product portfolio that spans data processing units (DPUs, the processors that manage the flow of data within a computing system) to optical and networking systems has helped Marvell increase its share of its customers' complex computing needs. And as cloud computing grows in importance in the decade ahead, Marvell is well positioned to grow.</p>\n<p>There are risks, however, as Marvell integrates its various new chip design subsidiaries. But the semiconductor company is already realizing positive results. Net losses were $276 million in the last quarter on revenue of $1.08 billion, but on an adjusted basis the company generated a robust $284 million profit. The non-adjusted and adjusted bottom-line results will converge over time as the amortized costs of the acquisitions are digested.</p>\n<p>At the end of the day, though, this is a top chip stock for the cloud computing age. The stock is up 140% since the start of 2020, and while I still like it for the long haul, I'd be really happy to load up on a lot more if it pulled back in price from all-time highs. Data centers are at the heart of modern business operations these days, and Marvell is helping make it happen.</p>\n<p><img src=\"https://static.tigerbbs.com/cc9de329c77d9f948cbec17e386e13a9\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Buy, compra, kaufe, achetez, köp Duolingo on the dips</h3>\n<p><b>Anders Bylund (Duolingo):</b> Language tutoring specialist Duolingo is off to the races. The stock has gained a market-stomping 46% since joining the public stock market at the end of July. Trading at a lofty 37 times trailing sales with negative earnings and cash flows, Duolingo is a value investor's worst nightmare right now.</p>\n<p>This little company is going places. I'm already a happy Duolingo shareholder and I'd be first in line to boost my holdings if another marketwide flight from high-priced growth stocks drags the stock back down. In fact, I might soon add a few shares to my holdings even if Duolingo stays aloft.</p>\n<p>The language training platform you see today is only the beginning of a much larger ambition. Duolingo founders Luis von Ahn and Severin Hacker started the service with the vision that \"free education will really change the world.\" That aspiration came first and the business opportunity followed much later, when von Ahn saw that voluntary donations and his MacArthur Genius Grant wouldn't be enough to let Duolingo change the world on a meaningful scale.</p>\n<p>Foreign languages provide a solid training ground for Duolingo's online tutoring services in a more general sense, eventually paving the way for launches of similar services for subjects such as math, physics, history, and underwater basket weaving. Developing this grand vision will take years -- and it should be well worth the effort.</p>\n<p>The global market for online learning services added up to a $226 billion revenue opportunity in 2020. Duolingo collected top-line sales of just $208 million over the last four quarters, which works out to a 0.1% slice of the addressable market. The long-term growth opportunity is massive.</p>\n<p>Furthermore, Duolingo is well equipped to make the most of this opening. It posted 47% year-over-year revenue growth in the company's first quarterly earnings report, and the balance sheet is squeaky clean with $115 million of cash reserves and just $8 million in long-term debts. It would take more than a temporary market storm to bring this company down.</p>\n<p>So take advantage of lower prices if and when Duolingo's stock is dragged down by the next market panic. The company is poised to spread its wings and fly. If the lofty valuation is the only thing holding you back, you should be prepared to take action on the inevitable dips along the way.</p>\n<h3>A downturn in China could bring an opportunity in Apple</h3>\n<p><b>Billy Duberstein (Apple):</b> iPhone giant Apple could get hit hard by a global market sell-off, especially if the <b>Evergrande </b>crisis causes a recession in China. Last quarter, China accounted for more than 18% of Apple's revenue, and a broader China recession could also cause a global slowdown outside the U.S., especially with China's other trading partners in Europe and the rest of the Asia-Pacific region.</p>\n<p>Of course, the last time Apple's stock was hit by Chinese worries was in late 2018 and early 2019. That proved to be a tremendous buying opportunity. In fact, Apple's stock has more than tripled off of that January 2019 bottom.</p>\n<p><img src=\"https://static.tigerbbs.com/1da803e990fe5738b1ab8d192691a45d\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p>\n<p>Data by YCharts.</p>\n<p>That's because while iPhone sales can be inconsistent and lumpy, over the long run, Apple's revenue should grow. Eventually, customers need to update their phones, even if they hold off during difficult economic times, and Apple users are generally incredibly loyal. The Apple device installed base continues to grow every quarter, and management has successfully grown its services business, which has much more recurring revenue, to about 21.4% of total revenue as of last quarter.</p>\n<p>It's true that Apple trades at a much higher earnings multiple than it did prior to 2020, and so its stock still has the possibility to fall significantly if the market gets scared. Yet its 28.5 P/E ratio today is still reasonable when considering its near-$200 billion cash pile, which should insulate this safe stock from any significant long-term danger.</p>\n<p>And while Apple is primarily known for the iPhone and its various computing devices, it will also spend over $20 billion in research and development this year as it continues to innovate. Apple is likely to extend its brand power into future products and services going forward, such as healthcare, AR/VR, autonomous systems and vehicles, and others. Even recent new endeavors, such as Apple's controversial foray into streaming, could surprise to the upside. After all, the Apple TV+ show <i>Ted Lasso</i> cleaned up at this year's Emmy awards. That's the fastest any new streaming service has won the Emmy for best show. Therefore, investors shouldn't discount Apple becoming a more formidable force in streaming TV, either.</p>\n<p>Basically, Apple is a cash-gushing, safe stock that still has a history of correcting in large market sell-offs. Given its consumer staple-like resilience and potential for future innovation, it's a prime target for investors should the market swoon.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks We're Ready to Buy if the Market Crashes This Month</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks We're Ready to Buy if the Market Crashes This Month\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-27 11:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/26/3-stocks-were-ready-to-buy-if-the-market-crashes-t/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>These tech stocks are riding secular growth trends, but would be especially good buys if there's a market pullback.\n\nKey Points\n\nMarvell Technology Group has transformed itself into a top data center ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/26/3-stocks-were-ready-to-buy-if-the-market-crashes-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DUOL":"多邻国","AAPL":"苹果"},"source_url":"https://www.fool.com/investing/2021/09/26/3-stocks-were-ready-to-buy-if-the-market-crashes-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2170108956","content_text":"These tech stocks are riding secular growth trends, but would be especially good buys if there's a market pullback.\n\nKey Points\n\nMarvell Technology Group has transformed itself into a top data center supplier.\nDuolingo is a language app, but it has big education aspirations.\nApple still has a big opportunity in China despite the recent troubles there.\n\nHistorically, the stock market crashes an average of once almost every two years (with a crash defined as a decline of 10% from highs). Stocks overall haven't suffered such a setback since the pandemic started a year and a half ago, so many investors worry that a 10% pullback is imminent.\nThe historical average is just that, though: an average. There's no telling when the market will crash and what will ultimately cause it to temporarily fall in value. But a focus on quality companies riding economic growth trends will set you up for long-term success no matter what the stock market does. Three Fool.com contributors think Marvell Technology Group (NASDAQ:MRVL), Duolingo (NASDAQ:DUOL), and Apple (NASDAQ:AAPL) are great buys right now, and would be especially great pickups if the market falls in the next month.\nDoubling down on data center hardware\nNicholas Rossolillo (Marvell Technology Group): Semiconductor designer Marvell is flying high this year -- and not just because of the global chip shortage. The company has made four major acquisitions since 2018, and a fifth one is currently pending. These takeovers have transformed Marvell's operations, reducing its reliance on consumer electronics and upping its game in data centers and 5G mobile networks.\nIn fact, Marvell said on its last earnings call that data center sales (40% of revenue) are poised to grow for years to come. Marvell's product portfolio that spans data processing units (DPUs, the processors that manage the flow of data within a computing system) to optical and networking systems has helped Marvell increase its share of its customers' complex computing needs. And as cloud computing grows in importance in the decade ahead, Marvell is well positioned to grow.\nThere are risks, however, as Marvell integrates its various new chip design subsidiaries. But the semiconductor company is already realizing positive results. Net losses were $276 million in the last quarter on revenue of $1.08 billion, but on an adjusted basis the company generated a robust $284 million profit. The non-adjusted and adjusted bottom-line results will converge over time as the amortized costs of the acquisitions are digested.\nAt the end of the day, though, this is a top chip stock for the cloud computing age. The stock is up 140% since the start of 2020, and while I still like it for the long haul, I'd be really happy to load up on a lot more if it pulled back in price from all-time highs. Data centers are at the heart of modern business operations these days, and Marvell is helping make it happen.\n\nImage source: Getty Images.\nBuy, compra, kaufe, achetez, köp Duolingo on the dips\nAnders Bylund (Duolingo): Language tutoring specialist Duolingo is off to the races. The stock has gained a market-stomping 46% since joining the public stock market at the end of July. Trading at a lofty 37 times trailing sales with negative earnings and cash flows, Duolingo is a value investor's worst nightmare right now.\nThis little company is going places. I'm already a happy Duolingo shareholder and I'd be first in line to boost my holdings if another marketwide flight from high-priced growth stocks drags the stock back down. In fact, I might soon add a few shares to my holdings even if Duolingo stays aloft.\nThe language training platform you see today is only the beginning of a much larger ambition. Duolingo founders Luis von Ahn and Severin Hacker started the service with the vision that \"free education will really change the world.\" That aspiration came first and the business opportunity followed much later, when von Ahn saw that voluntary donations and his MacArthur Genius Grant wouldn't be enough to let Duolingo change the world on a meaningful scale.\nForeign languages provide a solid training ground for Duolingo's online tutoring services in a more general sense, eventually paving the way for launches of similar services for subjects such as math, physics, history, and underwater basket weaving. Developing this grand vision will take years -- and it should be well worth the effort.\nThe global market for online learning services added up to a $226 billion revenue opportunity in 2020. Duolingo collected top-line sales of just $208 million over the last four quarters, which works out to a 0.1% slice of the addressable market. The long-term growth opportunity is massive.\nFurthermore, Duolingo is well equipped to make the most of this opening. It posted 47% year-over-year revenue growth in the company's first quarterly earnings report, and the balance sheet is squeaky clean with $115 million of cash reserves and just $8 million in long-term debts. It would take more than a temporary market storm to bring this company down.\nSo take advantage of lower prices if and when Duolingo's stock is dragged down by the next market panic. The company is poised to spread its wings and fly. If the lofty valuation is the only thing holding you back, you should be prepared to take action on the inevitable dips along the way.\nA downturn in China could bring an opportunity in Apple\nBilly Duberstein (Apple): iPhone giant Apple could get hit hard by a global market sell-off, especially if the Evergrande crisis causes a recession in China. Last quarter, China accounted for more than 18% of Apple's revenue, and a broader China recession could also cause a global slowdown outside the U.S., especially with China's other trading partners in Europe and the rest of the Asia-Pacific region.\nOf course, the last time Apple's stock was hit by Chinese worries was in late 2018 and early 2019. That proved to be a tremendous buying opportunity. In fact, Apple's stock has more than tripled off of that January 2019 bottom.\n\nData by YCharts.\nThat's because while iPhone sales can be inconsistent and lumpy, over the long run, Apple's revenue should grow. Eventually, customers need to update their phones, even if they hold off during difficult economic times, and Apple users are generally incredibly loyal. The Apple device installed base continues to grow every quarter, and management has successfully grown its services business, which has much more recurring revenue, to about 21.4% of total revenue as of last quarter.\nIt's true that Apple trades at a much higher earnings multiple than it did prior to 2020, and so its stock still has the possibility to fall significantly if the market gets scared. Yet its 28.5 P/E ratio today is still reasonable when considering its near-$200 billion cash pile, which should insulate this safe stock from any significant long-term danger.\nAnd while Apple is primarily known for the iPhone and its various computing devices, it will also spend over $20 billion in research and development this year as it continues to innovate. Apple is likely to extend its brand power into future products and services going forward, such as healthcare, AR/VR, autonomous systems and vehicles, and others. Even recent new endeavors, such as Apple's controversial foray into streaming, could surprise to the upside. After all, the Apple TV+ show Ted Lasso cleaned up at this year's Emmy awards. That's the fastest any new streaming service has won the Emmy for best show. Therefore, investors shouldn't discount Apple becoming a more formidable force in streaming TV, either.\nBasically, Apple is a cash-gushing, safe stock that still has a history of correcting in large market sell-offs. Given its consumer staple-like resilience and potential for future innovation, it's a prime target for investors should the market swoon.","news_type":1},"isVote":1,"tweetType":1,"viewCount":478,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":868655227,"gmtCreate":1632644062369,"gmtModify":1632646786154,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"What did i just see?? Wow","listText":"What did i just see?? Wow","text":"What did i just see?? Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/868655227","repostId":"1135042460","repostType":4,"isVote":1,"tweetType":1,"viewCount":368,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":868655841,"gmtCreate":1632644034883,"gmtModify":1632646789155,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Oh yeahhhh","listText":"Oh yeahhhh","text":"Oh yeahhhh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/868655841","repostId":"1136461867","repostType":4,"isVote":1,"tweetType":1,"viewCount":198,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":861540762,"gmtCreate":1632527261956,"gmtModify":1632712706485,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"There’s always ups and downs, fundamentally still strong","listText":"There’s always ups and downs, fundamentally still strong","text":"There’s always ups and downs, fundamentally still strong","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/861540762","repostId":"2170619785","repostType":4,"isVote":1,"tweetType":1,"viewCount":78,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":829759350,"gmtCreate":1633561143304,"gmtModify":1633561143508,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"True investors would have a tough mentality and are able to ride out market volatility. The weaker ones would sell at a loss and suffer","listText":"True investors would have a tough mentality and are able to ride out market volatility. The weaker ones would sell at a loss and suffer","text":"True investors would have a tough mentality and are able to ride out market volatility. The weaker ones would sell at a loss and suffer","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/829759350","repostId":"2173917919","repostType":4,"repost":{"id":"2173917919","pubTimestamp":1633524180,"share":"https://www.laohu8.com/m/news/2173917919?lang=&edition=full","pubTime":"2021-10-06 20:43","market":"us","language":"en","title":"Stocks Set to Fall Again: Is This the Secret to Making Money When Markets Plunge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2173917919","media":"Motley Fool","summary":"A certain type of investment is on the rise Wednesday morning.","content":"<p>Wall Street has been extremely turbulent lately, and on Wednesday morning, investors got another case of the jitters. Focusing on all the things that could go wrong in the market, major stock indexes were poised to lose substantial ground when the market opens. In premarket trading Wednesday morning as of 8 a.m. EDT, futures on the <b>Dow Jones Industrial Average </b>(DJINDICES:^DJI) were down 326 points to 33,857. Futures on the <b>S&amp;P 500 </b>(SNPINDEX:^GSPC) dropped 48 points to 4,286, and <b>Nasdaq Composite </b>(NASDAQINDEX:^IXIC) futures fell 186 points to 14,470.</p>\n<p>Stock market volatility levels have been on the rise, and many investors are looking to protect themselves against further declines by looking to the options market. A key measure of volatility, the <b>CBOE Volatility Index </b>(VOLATILITYINDICES:^VIX), has seen a couple of its biggest spikes all year come in the last couple of weeks. That has some investors looking for ways to profit -- and this morning, they're turning to exchange-traded funds designed to try to track the VIX.</p>\n<p><img src=\"https://static.tigerbbs.com/22719786dce6b2278c6f4132a5bc86ff\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Volatility ETFs and the VIX</h3>\n<p>The ETF universe has found ways to invest in nearly anything, and volatility is no exception. Because there's no way to invest directly in movements in the VIX, volatility ETFs concentrate on VIX futures contracts.</p>\n<p>One relatively simple exchange-traded volatility product is <b>iPath Series B S&amp;P 500 VIX Short-Term Futures </b>(NYSEMKT:VXX). This security is designed to track the daily movements in the front month and second month VIX futures contracts. Given this morning's rise in anticipated volatility, shares of the iPath volatility product are up more than 4% in pre-market trading.</p>\n<p>A similar product is <b>ProShares VIX Short-Term Futures ETF </b>(NYSEMKT:VIXY). It uses a slightly different methodology in selecting futures contracts to achieve the same goal. It's also up nearly 4% as of 8 a.m. EDT Wednesday.</p>\n<p>Those investors seeking an even larger gain from rising volatility levels can use leveraged volatility ETFs. The <b>ProShares Ultra VIX Short-Term Futures ETF </b>(NYSEMKT:UVXY) offers moves that are 1.5 times the corresponding daily movement of various VIX futures contracts. That multiple has the ProShares fund up nearly 6% in the pre-market session Wednesday.</p>\n<h3>The dangers of volatility ETFs</h3>\n<p>Investing in volatility is dangerous. The first thing to keep in mind is that these products are all designed to tie to <i>daily </i>returns, and that makes them less than ideal for long-term investors. For instance, looking at the iPath's history, it lost money every single year from 2009 to 2017, eked out a tiny positive return in 2018, lost two-thirds of its value in 2019, and climbed just 11% in 2020's turbulent stock market year. It's down more than 60% so far in 2021.</p>\n<p>However, the massive returns you can earn if you have perfect timing are tempting. From mid-February to mid-March in 2020, the iPath product jumped more than 320%. The ProShares Ultra volatility ETF gained nearly 700%. But you do have to have perfect timing on both ends -- by the end of April 2020, the funds had given back 50% to 60% of those gains. By the end of the year, the ProShares fund had actually dropped back to a net loss after its huge spike.</p>\n<p>Because of their big daily moves, volatility ETFs are attractive to short-term traders. For long-term investors, though, the better way to play volatility is to have cash on hand to buy attractive stocks when they're cheap after a downswing. The bargains you'll reap can end up being top performers in your portfolio.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks Set to Fall Again: Is This the Secret to Making Money When Markets Plunge?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks Set to Fall Again: Is This the Secret to Making Money When Markets Plunge?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-06 20:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/06/stocks-fall-again-secret-make-money-market-plunge/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Wall Street has been extremely turbulent lately, and on Wednesday morning, investors got another case of the jitters. Focusing on all the things that could go wrong in the market, major stock indexes ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/06/stocks-fall-again-secret-make-money-market-plunge/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UVXY":"1.5倍做多波动率指数短期期货ETF-ProShares","VIXY":"波动率短期期货指数ETF","VXX":"短期VIX期货ETN","SVXY":"0.5倍做空波动率指数短期期货ETF","TVIX":"二倍做多VIX波动率指数短期期权ETN"},"source_url":"https://www.fool.com/investing/2021/10/06/stocks-fall-again-secret-make-money-market-plunge/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2173917919","content_text":"Wall Street has been extremely turbulent lately, and on Wednesday morning, investors got another case of the jitters. Focusing on all the things that could go wrong in the market, major stock indexes were poised to lose substantial ground when the market opens. In premarket trading Wednesday morning as of 8 a.m. EDT, futures on the Dow Jones Industrial Average (DJINDICES:^DJI) were down 326 points to 33,857. Futures on the S&P 500 (SNPINDEX:^GSPC) dropped 48 points to 4,286, and Nasdaq Composite (NASDAQINDEX:^IXIC) futures fell 186 points to 14,470.\nStock market volatility levels have been on the rise, and many investors are looking to protect themselves against further declines by looking to the options market. A key measure of volatility, the CBOE Volatility Index (VOLATILITYINDICES:^VIX), has seen a couple of its biggest spikes all year come in the last couple of weeks. That has some investors looking for ways to profit -- and this morning, they're turning to exchange-traded funds designed to try to track the VIX.\n\nImage source: Getty Images.\nVolatility ETFs and the VIX\nThe ETF universe has found ways to invest in nearly anything, and volatility is no exception. Because there's no way to invest directly in movements in the VIX, volatility ETFs concentrate on VIX futures contracts.\nOne relatively simple exchange-traded volatility product is iPath Series B S&P 500 VIX Short-Term Futures (NYSEMKT:VXX). This security is designed to track the daily movements in the front month and second month VIX futures contracts. Given this morning's rise in anticipated volatility, shares of the iPath volatility product are up more than 4% in pre-market trading.\nA similar product is ProShares VIX Short-Term Futures ETF (NYSEMKT:VIXY). It uses a slightly different methodology in selecting futures contracts to achieve the same goal. It's also up nearly 4% as of 8 a.m. EDT Wednesday.\nThose investors seeking an even larger gain from rising volatility levels can use leveraged volatility ETFs. The ProShares Ultra VIX Short-Term Futures ETF (NYSEMKT:UVXY) offers moves that are 1.5 times the corresponding daily movement of various VIX futures contracts. That multiple has the ProShares fund up nearly 6% in the pre-market session Wednesday.\nThe dangers of volatility ETFs\nInvesting in volatility is dangerous. The first thing to keep in mind is that these products are all designed to tie to daily returns, and that makes them less than ideal for long-term investors. For instance, looking at the iPath's history, it lost money every single year from 2009 to 2017, eked out a tiny positive return in 2018, lost two-thirds of its value in 2019, and climbed just 11% in 2020's turbulent stock market year. It's down more than 60% so far in 2021.\nHowever, the massive returns you can earn if you have perfect timing are tempting. From mid-February to mid-March in 2020, the iPath product jumped more than 320%. The ProShares Ultra volatility ETF gained nearly 700%. But you do have to have perfect timing on both ends -- by the end of April 2020, the funds had given back 50% to 60% of those gains. By the end of the year, the ProShares fund had actually dropped back to a net loss after its huge spike.\nBecause of their big daily moves, volatility ETFs are attractive to short-term traders. For long-term investors, though, the better way to play volatility is to have cash on hand to buy attractive stocks when they're cheap after a downswing. The bargains you'll reap can end up being top performers in your portfolio.","news_type":1},"isVote":1,"tweetType":1,"viewCount":484,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":861540762,"gmtCreate":1632527261956,"gmtModify":1632712706485,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"There’s always ups and downs, fundamentally still strong","listText":"There’s always ups and downs, fundamentally still strong","text":"There’s always ups and downs, fundamentally still strong","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/861540762","repostId":"2170619785","repostType":4,"repost":{"id":"2170619785","pubTimestamp":1632518354,"share":"https://www.laohu8.com/m/news/2170619785?lang=&edition=full","pubTime":"2021-09-25 05:19","market":"us","language":"en","title":"Dow Jones, S&P 500 end with gains up after bumpy week, but Nike drags","url":"https://stock-news.laohu8.com/highlight/detail?id=2170619785","media":"The Straits Times","summary":"NEW YORK (REUTERS) - The Dow and S&P 500 edged higher on Friday (Sept 24) and ended a turbulent week","content":"<div>\n<p>NEW YORK (REUTERS) - The Dow and S&P 500 edged higher on Friday (Sept 24) and ended a turbulent week with slight increases, helped by gains in Tesla and Facebook that offset a tumble by Nike.\nAthletic...</p>\n\n<a href=\"http://www.straitstimes.com/business/companies-markets/dow-jones-sp-500-end-with-gains-up-after-bumpy-week-but-nike-drags\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow Jones, S&P 500 end with gains up after bumpy week, but Nike drags</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow Jones, S&P 500 end with gains up after bumpy week, but Nike drags\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-25 05:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/business/companies-markets/dow-jones-sp-500-end-with-gains-up-after-bumpy-week-but-nike-drags><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK (REUTERS) - The Dow and S&P 500 edged higher on Friday (Sept 24) and ended a turbulent week with slight increases, helped by gains in Tesla and Facebook that offset a tumble by Nike.\nAthletic...</p>\n\n<a href=\"http://www.straitstimes.com/business/companies-markets/dow-jones-sp-500-end-with-gains-up-after-bumpy-week-but-nike-drags\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","NKE":"耐克","SDS":"两倍做空标普500ETF",".SPX":"S&P 500 Index","OEX":"标普100","SSO":"两倍做多标普500ETF","UPRO":"三倍做多标普500ETF","IVV":"标普500指数ETF","SPXU":"三倍做空标普500ETF","SH":"标普500反向ETF",".DJI":"道琼斯","OEF":"标普100指数ETF-iShares","SPY":"标普500ETF",".IXIC":"NASDAQ Composite"},"source_url":"http://www.straitstimes.com/business/companies-markets/dow-jones-sp-500-end-with-gains-up-after-bumpy-week-but-nike-drags","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2170619785","content_text":"NEW YORK (REUTERS) - The Dow and S&P 500 edged higher on Friday (Sept 24) and ended a turbulent week with slight increases, helped by gains in Tesla and Facebook that offset a tumble by Nike.\nAthletic wear company Nike's shares fell 6.3% and were the biggest drag on the Dow and the S&P 500 after it delivered a downbeat sales forecast and warned of delays during the holiday shopping season, blaming a supply chain crunch.\nShares of footwear retailer Foot Locker also fell sharply. On the flip side, Facebook climbed 2% and Tesla rose 2.7%.\nThe S&P communication services sector climbed 0.7% and was the second-biggest sector gainer of the day after energy, up 0.8%.\nStocks bounced back from a sharp selloff at the start of the week tied in part to concerns over a default by China's Evergrande and its potential risk to global financial markets.\nOn Friday, Evergrande's electric car unit warned it faced an uncertain future unless it got a swift injection of cash, the clearest sign yet that the property developer's liquidity crisis is worsening in other parts of its business.\n\"You've had a good recovery from the lows\" this week, said Rick Meckler, partner, Cherry Lane Investments, a family investment office in New Vernon, New Jersey.\n\"With rates this low - even if they are going to move up slowly - and with the fiscal stimulus you'll probably see coming, I think investors still prefer stocks to any other asset class. Stocks remain in a weird way what investors see as the safe place.\"\nOn Wednesday, the Federal Reserve said it would reduce its monthly bond purchases \"soon\" and half of the Fed's policymakers projected borrowing costs will need to rise in 2022.\nThe Dow Jones Industrial Average rose 33.18 points, or 0.1%, to 34,798, the S&P 500 gained 6.5 points, or 0.15%, to 4,455.48 and the Nasdaq Composite dropped 4.55 points, or 0.03%, to 15,047.70.\nFor the week, the Dow was up 0.6%, the S&P 500 gained 0.5% and the Nasdaq was near flat.\nShares of cryptocurrency-related firms Coinbase Global, MicroStrategy Inc, Riot Blockchain and Marathon Patent Group fell after China's central bank put a ban on crypto trading and mining. \"It's been a very volatile week to say the least, so I think going into the last week of September the volatility is likely to continue especially with the end-of-the-quarter window dressing,\" said Peter Cardillo, chief market economist at Spartan Capital Securities in New York.\nInvestors are also looking for signs of progress on President Joe Biden's spending and budget bills.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.40-to-1 ratio favored decliners.\nThe S&P 500 posted 21 new 52-week highs and 6 new lows; the Nasdaq Composite recorded 82 new highs and 73 new lows.\nVolume on US exchanges was 9.00 billion shares, compared with the 10.11 billion average for the full session over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":78,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865406495,"gmtCreate":1633008797466,"gmtModify":1633008798660,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Oh yeahhh","listText":"Oh yeahhh","text":"Oh yeahhh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865406495","repostId":"1190243332","repostType":4,"repost":{"id":"1190243332","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633008705,"share":"https://www.laohu8.com/m/news/1190243332?lang=&edition=full","pubTime":"2021-09-30 21:31","market":"us","language":"en","title":"Stocks rise slightly as Wall Street tries to end losing month on a high note","url":"https://stock-news.laohu8.com/highlight/detail?id=1190243332","media":"Tiger Newspress","summary":"U.S. stocks rose slightly on Thursday as investors get to close out a volatile and losing month for ","content":"<p>U.S. stocks rose slightly on Thursday as investors get to close out a volatile and losing month for stocks.</p>\n<p>The Dow Jones Industrial Average gained 107 points, or 0.3%. The S&amp;P 500 added 0.4% and Nasdaq Composite gained 0.6%.</p>\n<p>Tech stocks bounced a bit in morning trading after struggling this week because of a rapid rise in rates. The&nbsp;10-year Treasury yield&nbsp;was little changed in early trading.</p>\n<p>Chip stocks, including Nvidia and Micron, were higher after weighing on the broader market on Wednesday. Facebook and Apple saw modest gains in early trading, while Netflix jumped more than 2%.</p>\n<p>Stocks also got a boost as Senate Majority Leader Chuck Schumer said late Wednesday that the chamber had reached a deal to avoid a government shutdown this week. Schumer said&nbsp;he would schedule a vote on Thursday&nbsp;for the stopgap measure that would keep the government running into early December. The deal would still need to pass the House.</p>\n<p>For the month, the Dow is down 2.7%, the S&amp;P 500 is off by 3.6% and the Nasdaq Composite has shed 4.9%. September has lived up to its losing reputation with the market beset by fears of a China property crisis, rising inflation and a late interest rate surge sparked by the Federal Reserve signaling it would start removing stimulus soon.</p>\n<p>\"We wouldn't get caught up in any end-of-quarter machinations today and continue to advise fading rallies (especially in tech) as the coming weeks will stay rocky,\" wrote Adam Crisafulli of Vital Knowledge.</p>\n<p>The 10-year Treasury yield fell 3 basis points to 1.52% on Thursday (1 basis point equals 0.01%). The rate was at 1.30% to end August before surging to end this month.</p>\n<p>September’s losses have led to a middling third quarter for the market. For the 3-month period, the Dow is slightly in the red, while the Nasdaq Composite is just about flat. The S&amp;P 500 is up 1.4%. The S&amp;P 500 is still up 16% on the year.</p>\n<p>October has a reputation for some violent sell-offs but overall is typically the start of a better seasonal performance for stocks. The S&amp;P 500 averages a 0.8% gain for the month, according to the Stock Trader’s Almanac.</p>\n<p>“September lived up to its reputation and dented stock portfolio returns, but not too badly,” wrote Ed Yardeni of Yardeni Research. “There has been a lot of concern that higher wages, higher energy prices, and higher transportation costs will weigh on earnings for the remainder of this year and into 2022. It’s certainly something we’ll be tracking. But so far, analysts remain relatively sanguine.”</p>\n<p>Concerns about inflation and supply chain issues continued to hamper stocks.Shares of Bed Bath &amp; Beyond fell more than 28%&nbsp;in morning&nbsp; trading after the company said those issues hurt the company’s second quarter results, and the news also weighed on fellow retail stocks.</p>\n<p>Fed Chair Jerome Powell will testify to the House Financial Services Committee at 10 a.m. ET Thursday alongside Treasury Secretary Janet Yellen. Powell&nbsp;told a European Central Bank panel on Wednesday&nbsp;that he was frustrated by persistent inflation.</p>\n<p>“It’s also frustrating to see the bottlenecks and supply chain problems not getting better — in fact at the margins apparently getting a little bit worse,” Powell said. “We see that continuing into next year probably, and holding up inflation longer than we had thought.”</p>\n<p>On the data front,initial jobless claims&nbsp;for the prior week came in at 362,000. Economists are expecting a print of 335,000, according to Dow Jones.</p>\n<p>The Dow and S&amp;P 500 inched higher during regular trading Wednesday. The 30-stock Dow advanced about 90 points for its fifth positive session in the last six, while the S&amp;P 500 gained 0.16%, breaking a 2-day losing streak.</p>\n<p>The Nasdaq Composite, meanwhile, declined 0.24% for its fourth straight negative session. The technology sector declined again on Wednesday and is now down 4% for the week, making it the worst-performing S&amp;P group.</p>\n<p>The tech decline came as the 10-year Treasury yield hit a high of 1.56% on Wednesday, after rising to 1.567% on Tuesday. The move higher is pressuring tech stocks since it makes future cash flows look less attractive.</p>\n<p>Wells Fargo noted that pullbacks are to be expected. \"This is a normal re-pricing of risk based on a higher cost of capital and greater market uncertainty,\" the firm said Wednesday in a note to clients.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks rise slightly as Wall Street tries to end losing month on a high note</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks rise slightly as Wall Street tries to end losing month on a high note\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-30 21:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stocks rose slightly on Thursday as investors get to close out a volatile and losing month for stocks.</p>\n<p>The Dow Jones Industrial Average gained 107 points, or 0.3%. The S&amp;P 500 added 0.4% and Nasdaq Composite gained 0.6%.</p>\n<p>Tech stocks bounced a bit in morning trading after struggling this week because of a rapid rise in rates. The&nbsp;10-year Treasury yield&nbsp;was little changed in early trading.</p>\n<p>Chip stocks, including Nvidia and Micron, were higher after weighing on the broader market on Wednesday. Facebook and Apple saw modest gains in early trading, while Netflix jumped more than 2%.</p>\n<p>Stocks also got a boost as Senate Majority Leader Chuck Schumer said late Wednesday that the chamber had reached a deal to avoid a government shutdown this week. Schumer said&nbsp;he would schedule a vote on Thursday&nbsp;for the stopgap measure that would keep the government running into early December. The deal would still need to pass the House.</p>\n<p>For the month, the Dow is down 2.7%, the S&amp;P 500 is off by 3.6% and the Nasdaq Composite has shed 4.9%. September has lived up to its losing reputation with the market beset by fears of a China property crisis, rising inflation and a late interest rate surge sparked by the Federal Reserve signaling it would start removing stimulus soon.</p>\n<p>\"We wouldn't get caught up in any end-of-quarter machinations today and continue to advise fading rallies (especially in tech) as the coming weeks will stay rocky,\" wrote Adam Crisafulli of Vital Knowledge.</p>\n<p>The 10-year Treasury yield fell 3 basis points to 1.52% on Thursday (1 basis point equals 0.01%). The rate was at 1.30% to end August before surging to end this month.</p>\n<p>September’s losses have led to a middling third quarter for the market. For the 3-month period, the Dow is slightly in the red, while the Nasdaq Composite is just about flat. The S&amp;P 500 is up 1.4%. The S&amp;P 500 is still up 16% on the year.</p>\n<p>October has a reputation for some violent sell-offs but overall is typically the start of a better seasonal performance for stocks. The S&amp;P 500 averages a 0.8% gain for the month, according to the Stock Trader’s Almanac.</p>\n<p>“September lived up to its reputation and dented stock portfolio returns, but not too badly,” wrote Ed Yardeni of Yardeni Research. “There has been a lot of concern that higher wages, higher energy prices, and higher transportation costs will weigh on earnings for the remainder of this year and into 2022. It’s certainly something we’ll be tracking. But so far, analysts remain relatively sanguine.”</p>\n<p>Concerns about inflation and supply chain issues continued to hamper stocks.Shares of Bed Bath &amp; Beyond fell more than 28%&nbsp;in morning&nbsp; trading after the company said those issues hurt the company’s second quarter results, and the news also weighed on fellow retail stocks.</p>\n<p>Fed Chair Jerome Powell will testify to the House Financial Services Committee at 10 a.m. ET Thursday alongside Treasury Secretary Janet Yellen. Powell&nbsp;told a European Central Bank panel on Wednesday&nbsp;that he was frustrated by persistent inflation.</p>\n<p>“It’s also frustrating to see the bottlenecks and supply chain problems not getting better — in fact at the margins apparently getting a little bit worse,” Powell said. “We see that continuing into next year probably, and holding up inflation longer than we had thought.”</p>\n<p>On the data front,initial jobless claims&nbsp;for the prior week came in at 362,000. Economists are expecting a print of 335,000, according to Dow Jones.</p>\n<p>The Dow and S&amp;P 500 inched higher during regular trading Wednesday. The 30-stock Dow advanced about 90 points for its fifth positive session in the last six, while the S&amp;P 500 gained 0.16%, breaking a 2-day losing streak.</p>\n<p>The Nasdaq Composite, meanwhile, declined 0.24% for its fourth straight negative session. The technology sector declined again on Wednesday and is now down 4% for the week, making it the worst-performing S&amp;P group.</p>\n<p>The tech decline came as the 10-year Treasury yield hit a high of 1.56% on Wednesday, after rising to 1.567% on Tuesday. The move higher is pressuring tech stocks since it makes future cash flows look less attractive.</p>\n<p>Wells Fargo noted that pullbacks are to be expected. \"This is a normal re-pricing of risk based on a higher cost of capital and greater market uncertainty,\" the firm said Wednesday in a note to clients.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190243332","content_text":"U.S. stocks rose slightly on Thursday as investors get to close out a volatile and losing month for stocks.\nThe Dow Jones Industrial Average gained 107 points, or 0.3%. The S&P 500 added 0.4% and Nasdaq Composite gained 0.6%.\nTech stocks bounced a bit in morning trading after struggling this week because of a rapid rise in rates. The 10-year Treasury yield was little changed in early trading.\nChip stocks, including Nvidia and Micron, were higher after weighing on the broader market on Wednesday. Facebook and Apple saw modest gains in early trading, while Netflix jumped more than 2%.\nStocks also got a boost as Senate Majority Leader Chuck Schumer said late Wednesday that the chamber had reached a deal to avoid a government shutdown this week. Schumer said he would schedule a vote on Thursday for the stopgap measure that would keep the government running into early December. The deal would still need to pass the House.\nFor the month, the Dow is down 2.7%, the S&P 500 is off by 3.6% and the Nasdaq Composite has shed 4.9%. September has lived up to its losing reputation with the market beset by fears of a China property crisis, rising inflation and a late interest rate surge sparked by the Federal Reserve signaling it would start removing stimulus soon.\n\"We wouldn't get caught up in any end-of-quarter machinations today and continue to advise fading rallies (especially in tech) as the coming weeks will stay rocky,\" wrote Adam Crisafulli of Vital Knowledge.\nThe 10-year Treasury yield fell 3 basis points to 1.52% on Thursday (1 basis point equals 0.01%). The rate was at 1.30% to end August before surging to end this month.\nSeptember’s losses have led to a middling third quarter for the market. For the 3-month period, the Dow is slightly in the red, while the Nasdaq Composite is just about flat. The S&P 500 is up 1.4%. The S&P 500 is still up 16% on the year.\nOctober has a reputation for some violent sell-offs but overall is typically the start of a better seasonal performance for stocks. The S&P 500 averages a 0.8% gain for the month, according to the Stock Trader’s Almanac.\n“September lived up to its reputation and dented stock portfolio returns, but not too badly,” wrote Ed Yardeni of Yardeni Research. “There has been a lot of concern that higher wages, higher energy prices, and higher transportation costs will weigh on earnings for the remainder of this year and into 2022. It’s certainly something we’ll be tracking. But so far, analysts remain relatively sanguine.”\nConcerns about inflation and supply chain issues continued to hamper stocks.Shares of Bed Bath & Beyond fell more than 28% in morning  trading after the company said those issues hurt the company’s second quarter results, and the news also weighed on fellow retail stocks.\nFed Chair Jerome Powell will testify to the House Financial Services Committee at 10 a.m. ET Thursday alongside Treasury Secretary Janet Yellen. Powell told a European Central Bank panel on Wednesday that he was frustrated by persistent inflation.\n“It’s also frustrating to see the bottlenecks and supply chain problems not getting better — in fact at the margins apparently getting a little bit worse,” Powell said. “We see that continuing into next year probably, and holding up inflation longer than we had thought.”\nOn the data front,initial jobless claims for the prior week came in at 362,000. Economists are expecting a print of 335,000, according to Dow Jones.\nThe Dow and S&P 500 inched higher during regular trading Wednesday. The 30-stock Dow advanced about 90 points for its fifth positive session in the last six, while the S&P 500 gained 0.16%, breaking a 2-day losing streak.\nThe Nasdaq Composite, meanwhile, declined 0.24% for its fourth straight negative session. The technology sector declined again on Wednesday and is now down 4% for the week, making it the worst-performing S&P group.\nThe tech decline came as the 10-year Treasury yield hit a high of 1.56% on Wednesday, after rising to 1.567% on Tuesday. The move higher is pressuring tech stocks since it makes future cash flows look less attractive.\nWells Fargo noted that pullbacks are to be expected. \"This is a normal re-pricing of risk based on a higher cost of capital and greater market uncertainty,\" the firm said Wednesday in a note to clients.","news_type":1},"isVote":1,"tweetType":1,"viewCount":530,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829323220,"gmtCreate":1633475890050,"gmtModify":1633475955035,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"$PLTR oh yeah!!","listText":"$PLTR oh yeah!!","text":"$PLTR oh yeah!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/829323220","repostId":"1194519706","repostType":4,"repost":{"id":"1194519706","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633474388,"share":"https://www.laohu8.com/m/news/1194519706?lang=&edition=full","pubTime":"2021-10-06 06:53","market":"us","language":"en","title":"Palantir stock rallies 13% on $823 million Army contract","url":"https://stock-news.laohu8.com/highlight/detail?id=1194519706","media":"Tiger Newspress","summary":"Palantir Technologies Inc. shares rallied in the extended session Tuesday after the data-software co","content":"<p>Palantir Technologies Inc.&nbsp;shares rallied in the extended session Tuesday after the data-software company said it was selected for a U.S. Army intelligence program contract. Palantir shares surged 13% after hours, following a 0.2% rise to close at $23.21.</p>\n<p><img src=\"https://static.tigerbbs.com/1343e5e0bb5b0de52556fa7f10c66fe0\" tg-width=\"850\" tg-height=\"624\" width=\"100%\" height=\"auto\"></p>\n<p>Palantir Technologies Inc.&nbsp;announced it has been selected by the U.S. Army’s Program Manager for Intelligence Systems and Analytics to deliver the Army’s Intelligence data fabric and analytics foundation for the Capability Drop 2 (CD-2) program.</p>\n<p>Palantir was selected to progress to the next phase of the Army’s competitive $823m indefinite delivery, indefinite quantity (IDIQ) contract. After collaborating with the Army on a successful “Test, Fix, Test” process, Palantir will support the Army as they proceed through final testing and fielding.</p>\n<p>Palantir will deploy the Palantir Gotham Platform to support Army Intelligence users worldwide with a globally federated Intelligence data fabric and analytics platform spanning multiple security classifications. This capability will field modern data integration, correlation, fusion, and analytic capabilities that prepare the Army for the next fight against emerging near peer threats.</p>\n<p>The Gotham platform is an operating system for defense decision making and is specifically designed to connect the dots between disparate sources. The Army Intelligence community will use this capability to modernize their data foundation by migrating legacy programs to CD-2. The Army will also use CD-2 to serve as an enabler for future modernization efforts supporting Joint All Domain Operations.</p>\n<p>CD-2 is one of several efforts Palantir is working on with PEO IEW&amp;S to modernize the Army’s intelligence enterprise, alongside Capability Drop 1 (CD-1) and the Tactical Intelligence Targeting Access Node (TITAN) programs.</p>\n<p>“We look forward to the continued partnership with PEO IEW&amp;S and the Army’s Intelligence Community in providing new and exciting technology that help them in their modernization efforts,” said Doug Philippone, Palantir’s Global Defense Lead.</p>\n<p><b>About Palantir Technologies</b></p>\n<p>Palantir Technologies is a software company that builds enterprise data platforms for use by organizations with complex and sensitive data environments. From building safer cars and planes, to discovering new drugs and combating terrorism, Palantir helps customers across the public, private, and nonprofit sectors transform the way they use their data.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir stock rallies 13% on $823 million Army contract</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir stock rallies 13% on $823 million Army contract\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-06 06:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Palantir Technologies Inc.&nbsp;shares rallied in the extended session Tuesday after the data-software company said it was selected for a U.S. Army intelligence program contract. Palantir shares surged 13% after hours, following a 0.2% rise to close at $23.21.</p>\n<p><img src=\"https://static.tigerbbs.com/1343e5e0bb5b0de52556fa7f10c66fe0\" tg-width=\"850\" tg-height=\"624\" width=\"100%\" height=\"auto\"></p>\n<p>Palantir Technologies Inc.&nbsp;announced it has been selected by the U.S. Army’s Program Manager for Intelligence Systems and Analytics to deliver the Army’s Intelligence data fabric and analytics foundation for the Capability Drop 2 (CD-2) program.</p>\n<p>Palantir was selected to progress to the next phase of the Army’s competitive $823m indefinite delivery, indefinite quantity (IDIQ) contract. After collaborating with the Army on a successful “Test, Fix, Test” process, Palantir will support the Army as they proceed through final testing and fielding.</p>\n<p>Palantir will deploy the Palantir Gotham Platform to support Army Intelligence users worldwide with a globally federated Intelligence data fabric and analytics platform spanning multiple security classifications. This capability will field modern data integration, correlation, fusion, and analytic capabilities that prepare the Army for the next fight against emerging near peer threats.</p>\n<p>The Gotham platform is an operating system for defense decision making and is specifically designed to connect the dots between disparate sources. The Army Intelligence community will use this capability to modernize their data foundation by migrating legacy programs to CD-2. The Army will also use CD-2 to serve as an enabler for future modernization efforts supporting Joint All Domain Operations.</p>\n<p>CD-2 is one of several efforts Palantir is working on with PEO IEW&amp;S to modernize the Army’s intelligence enterprise, alongside Capability Drop 1 (CD-1) and the Tactical Intelligence Targeting Access Node (TITAN) programs.</p>\n<p>“We look forward to the continued partnership with PEO IEW&amp;S and the Army’s Intelligence Community in providing new and exciting technology that help them in their modernization efforts,” said Doug Philippone, Palantir’s Global Defense Lead.</p>\n<p><b>About Palantir Technologies</b></p>\n<p>Palantir Technologies is a software company that builds enterprise data platforms for use by organizations with complex and sensitive data environments. From building safer cars and planes, to discovering new drugs and combating terrorism, Palantir helps customers across the public, private, and nonprofit sectors transform the way they use their data.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194519706","content_text":"Palantir Technologies Inc. shares rallied in the extended session Tuesday after the data-software company said it was selected for a U.S. Army intelligence program contract. Palantir shares surged 13% after hours, following a 0.2% rise to close at $23.21.\n\nPalantir Technologies Inc. announced it has been selected by the U.S. Army’s Program Manager for Intelligence Systems and Analytics to deliver the Army’s Intelligence data fabric and analytics foundation for the Capability Drop 2 (CD-2) program.\nPalantir was selected to progress to the next phase of the Army’s competitive $823m indefinite delivery, indefinite quantity (IDIQ) contract. After collaborating with the Army on a successful “Test, Fix, Test” process, Palantir will support the Army as they proceed through final testing and fielding.\nPalantir will deploy the Palantir Gotham Platform to support Army Intelligence users worldwide with a globally federated Intelligence data fabric and analytics platform spanning multiple security classifications. This capability will field modern data integration, correlation, fusion, and analytic capabilities that prepare the Army for the next fight against emerging near peer threats.\nThe Gotham platform is an operating system for defense decision making and is specifically designed to connect the dots between disparate sources. The Army Intelligence community will use this capability to modernize their data foundation by migrating legacy programs to CD-2. The Army will also use CD-2 to serve as an enabler for future modernization efforts supporting Joint All Domain Operations.\nCD-2 is one of several efforts Palantir is working on with PEO IEW&S to modernize the Army’s intelligence enterprise, alongside Capability Drop 1 (CD-1) and the Tactical Intelligence Targeting Access Node (TITAN) programs.\n“We look forward to the continued partnership with PEO IEW&S and the Army’s Intelligence Community in providing new and exciting technology that help them in their modernization efforts,” said Doug Philippone, Palantir’s Global Defense Lead.\nAbout Palantir Technologies\nPalantir Technologies is a software company that builds enterprise data platforms for use by organizations with complex and sensitive data environments. From building safer cars and planes, to discovering new drugs and combating terrorism, Palantir helps customers across the public, private, and nonprofit sectors transform the way they use their data.","news_type":1},"isVote":1,"tweetType":1,"viewCount":345,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879290034,"gmtCreate":1636725799060,"gmtModify":1636725799135,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good read, but take it with a pinch of salt","listText":"Good read, but take it with a pinch of salt","text":"Good read, but take it with a pinch of salt","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879290034","repostId":"2182094779","repostType":2,"repost":{"id":"2182094779","pubTimestamp":1636723680,"share":"https://www.laohu8.com/m/news/2182094779?lang=&edition=full","pubTime":"2021-11-12 21:28","market":"us","language":"en","title":"The Smartest Stocks to Buy With $20 Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2182094779","media":"Motley Fool","summary":"A small amount of money can go a long way when invested in these top-notch stocks.","content":"<p>Time and again, Wall Street has shown investors the power of patience.</p>\n<p>Over the past 71 years, the broad-based <b>S&amp;P 500</b> has undergone 38 double-digit percentage corrections. Despite the regularity of these moves lower, every crash and correction throughout this period was eventually erased by a bull market rally. To put things succinctly, if investors buy great companies and allow their investment theses to play out over long periods of time, their chances of building wealth is very high.</p>\n<p>Best of all, with most online brokerages discarding minimum deposit requirements and commission fees, investors can begin or further their trek to financial independence with any amount of cash -- even $20. If you have $20 ready to put to work in the market, and it won't be needed to cover bills or other essential costs, the following trio of companies are the smartest stocks to buy right now.</p>\n<h2>Exelixis</h2>\n<p>One of the savviest stocks patient investors can buy right now with $20 is cancer-drug developer <b>Exelixis</b> (NASDAQ:EXEL).</p>\n<p>Last week, Exelixis announced its third-quarter operating results, which failed to hit the mark and sent its shares down by more than 10%. Sales of lead-drug Cabometyx were shy of Wall Street's expectations, which caused Exelixis to lower the upper end of its full-year sales outlook. Generally, lowering sales expectations will be met with frowns on Wall Street.</p>\n<p>However, this short-term weakness should be viewed as an opportunity, especially with the company's price-to-earnings-growth ratio (PEG ratio) below 0.4. A PEG ratio below 1 is typically considered \"undervalued.\"</p>\n<p>Although the landscape for first-line advanced renal cell carcinoma (RCC) is competitive, Cabometyx has demonstrated the ability to grow sales by a sustained double-digit percentage in RCC and advanced hepatocellular carcinoma. On an annual run-rate basis, Cabometyx is pacing more than $1 billion in sales -- and it's not done growing.</p>\n<p>More importantly, Exelixis' lead drug is being examined in close to six dozen clinical trials as a monotherapy or combination treatment. If even a handful of these trials yield a positive result, label-expansion opportunities and organic growth could send Cabometyx to north of $2 billion in peak annual sales.</p>\n<p>Additionally, Exelixis' robust cash position ($1.8 billion in cash, cash equivalents, and restricted cash) and healthy operating cash flow have allowed it to reignite its internal research engine. This includes advancing internally developed compounds into phase 1 studies, as well as signing collaboration agreements to potentially expand its cancer-drug pipeline.</p>\n<p>It's not often you can marry growth and value with the same company, but that's exactly what investors can do with biotech stock Exelixis.</p>\n<h2>Jushi Holdings</h2>\n<p>Some of the most deeply discounted growth stocks can be found in the marijuana industry, which is why U.S. multi-state operator (MSO) <b>Jushi Holdings</b> (OTC:JUSHF) makes for a smart buy with $20.</p>\n<p>To start with, don't be concerned about a lack of cannabis reform in Washington. While life would undoubtedly be easier for pot stocks if lawmakers would simply follow the overwhelming will of the public and legalize cannabis, allowing individual states to legalize and regulate their pot industries is working fine. Thus far, 36 states have given the green light to weed in some capacity, which is providing growth opportunities for MSOs like Jushi.</p>\n<p>In relative terms, Jushi is a small fry, with only 26 operating dispensaries at the moment. Comparatively, a handful of MSOs have in the neighborhood of (or more than) 100 open locations. But Jushi isn't about reckless expansion. Its management team favors methodical expansion in core markets. For Jushi, these core states are Pennsylvania, Illinois, and Virginia.</p>\n<p>The reason management has chosen these states is due to their billion-dollar sales potential (Illinois hit $1 billion in legal pot revenue in 2020) and their limited-license status. In limited-license cannabis markets, regulators purposely limit how many dispensary licenses are issued in total, as well as to a single business. For a smaller player like Jushi, this competitive protection ensures it'll have a fair shot to build up its brand(s) and garner a loyal following in these core markets.</p>\n<p>Something else impressive about Jushi, and <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the reasons I plan to be a long-term shareholder, is the participation of management and insiders. Of the first $250 million raised by the company, $45 million came from insiders and execs. When leadership has skin in the game right alongside their investors, good things tend to happen.</p>\n<p>Jushi is expected to turn the corner to recurring profitability in 2022 and the company's growing sales faster than virtually all other MSOs. The company checks all the appropriate boxes for growth investors.</p>\n<h2>Viatris</h2>\n<p>On the other hand, if value runs through your blood, generic-drug giant <b>Viatris</b> (NASDAQ:VTRS) is one of the smartest stocks you can buy right now with $20.</p>\n<p>Roughly a year ago, Viatris was born from the combination of <b>Pfizer</b>'s established drug unit Upjohn with generic-drug developer Mylan. Due to generic-drug price weakness throughout the industry, the company's first year as a public company has been one to forget. However, this near-term underperformance represents the perfect opportunity for patient investors to nab an exceptionally inexpensive and profitable drug stock.</p>\n<p>There were a number of reasons Upjohn and Mylan tied the knot. First off, there were clear-cut cost synergies. The company expects to recognize more than $500 million in cost synergies this year, with well over $1 billion in annual cost reductions by 2023.</p>\n<p>As a combined company, Viatris is also in a better position to tackle its outstanding debt. Through the first six months of 2021, $1.15 billion in debt was repaid. By the end of 2023, $6.5 billion in debt should be repaid, which represents a quarter of the company's combined debt ($26 billion), as of November 2020.</p>\n<p>Beyond just trimming the fat, Viatris should be able to kick-start its internal drug research in 2024 once debt levels are reduced to more favorable levels. Keep in mind that new drug research would come atop existing biosimilar clinical trials, which are expected to generate billions of dollars in future sales.</p>\n<p>Viatris won't deliver jaw-dropping growth like Jushi, or even double-digit annual sales upside like Exelixis. But with a steadiness to generic-drug demand and an improving balance sheet, Viatris' forward price-to-earnings ratio below 4 simply doesn't do its stock justice.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Smartest Stocks to Buy With $20 Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Smartest Stocks to Buy With $20 Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-12 21:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/12/the-smartest-stocks-to-buy-with-20-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Time and again, Wall Street has shown investors the power of patience.\nOver the past 71 years, the broad-based S&P 500 has undergone 38 double-digit percentage corrections. Despite the regularity of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/12/the-smartest-stocks-to-buy-with-20-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"EXEL":"伊克力西斯","VTRS":"Viatris Inc.","JUSHF":"Jushi Holdings Inc."},"source_url":"https://www.fool.com/investing/2021/11/12/the-smartest-stocks-to-buy-with-20-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2182094779","content_text":"Time and again, Wall Street has shown investors the power of patience.\nOver the past 71 years, the broad-based S&P 500 has undergone 38 double-digit percentage corrections. Despite the regularity of these moves lower, every crash and correction throughout this period was eventually erased by a bull market rally. To put things succinctly, if investors buy great companies and allow their investment theses to play out over long periods of time, their chances of building wealth is very high.\nBest of all, with most online brokerages discarding minimum deposit requirements and commission fees, investors can begin or further their trek to financial independence with any amount of cash -- even $20. If you have $20 ready to put to work in the market, and it won't be needed to cover bills or other essential costs, the following trio of companies are the smartest stocks to buy right now.\nExelixis\nOne of the savviest stocks patient investors can buy right now with $20 is cancer-drug developer Exelixis (NASDAQ:EXEL).\nLast week, Exelixis announced its third-quarter operating results, which failed to hit the mark and sent its shares down by more than 10%. Sales of lead-drug Cabometyx were shy of Wall Street's expectations, which caused Exelixis to lower the upper end of its full-year sales outlook. Generally, lowering sales expectations will be met with frowns on Wall Street.\nHowever, this short-term weakness should be viewed as an opportunity, especially with the company's price-to-earnings-growth ratio (PEG ratio) below 0.4. A PEG ratio below 1 is typically considered \"undervalued.\"\nAlthough the landscape for first-line advanced renal cell carcinoma (RCC) is competitive, Cabometyx has demonstrated the ability to grow sales by a sustained double-digit percentage in RCC and advanced hepatocellular carcinoma. On an annual run-rate basis, Cabometyx is pacing more than $1 billion in sales -- and it's not done growing.\nMore importantly, Exelixis' lead drug is being examined in close to six dozen clinical trials as a monotherapy or combination treatment. If even a handful of these trials yield a positive result, label-expansion opportunities and organic growth could send Cabometyx to north of $2 billion in peak annual sales.\nAdditionally, Exelixis' robust cash position ($1.8 billion in cash, cash equivalents, and restricted cash) and healthy operating cash flow have allowed it to reignite its internal research engine. This includes advancing internally developed compounds into phase 1 studies, as well as signing collaboration agreements to potentially expand its cancer-drug pipeline.\nIt's not often you can marry growth and value with the same company, but that's exactly what investors can do with biotech stock Exelixis.\nJushi Holdings\nSome of the most deeply discounted growth stocks can be found in the marijuana industry, which is why U.S. multi-state operator (MSO) Jushi Holdings (OTC:JUSHF) makes for a smart buy with $20.\nTo start with, don't be concerned about a lack of cannabis reform in Washington. While life would undoubtedly be easier for pot stocks if lawmakers would simply follow the overwhelming will of the public and legalize cannabis, allowing individual states to legalize and regulate their pot industries is working fine. Thus far, 36 states have given the green light to weed in some capacity, which is providing growth opportunities for MSOs like Jushi.\nIn relative terms, Jushi is a small fry, with only 26 operating dispensaries at the moment. Comparatively, a handful of MSOs have in the neighborhood of (or more than) 100 open locations. But Jushi isn't about reckless expansion. Its management team favors methodical expansion in core markets. For Jushi, these core states are Pennsylvania, Illinois, and Virginia.\nThe reason management has chosen these states is due to their billion-dollar sales potential (Illinois hit $1 billion in legal pot revenue in 2020) and their limited-license status. In limited-license cannabis markets, regulators purposely limit how many dispensary licenses are issued in total, as well as to a single business. For a smaller player like Jushi, this competitive protection ensures it'll have a fair shot to build up its brand(s) and garner a loyal following in these core markets.\nSomething else impressive about Jushi, and one of the reasons I plan to be a long-term shareholder, is the participation of management and insiders. Of the first $250 million raised by the company, $45 million came from insiders and execs. When leadership has skin in the game right alongside their investors, good things tend to happen.\nJushi is expected to turn the corner to recurring profitability in 2022 and the company's growing sales faster than virtually all other MSOs. The company checks all the appropriate boxes for growth investors.\nViatris\nOn the other hand, if value runs through your blood, generic-drug giant Viatris (NASDAQ:VTRS) is one of the smartest stocks you can buy right now with $20.\nRoughly a year ago, Viatris was born from the combination of Pfizer's established drug unit Upjohn with generic-drug developer Mylan. Due to generic-drug price weakness throughout the industry, the company's first year as a public company has been one to forget. However, this near-term underperformance represents the perfect opportunity for patient investors to nab an exceptionally inexpensive and profitable drug stock.\nThere were a number of reasons Upjohn and Mylan tied the knot. First off, there were clear-cut cost synergies. The company expects to recognize more than $500 million in cost synergies this year, with well over $1 billion in annual cost reductions by 2023.\nAs a combined company, Viatris is also in a better position to tackle its outstanding debt. Through the first six months of 2021, $1.15 billion in debt was repaid. By the end of 2023, $6.5 billion in debt should be repaid, which represents a quarter of the company's combined debt ($26 billion), as of November 2020.\nBeyond just trimming the fat, Viatris should be able to kick-start its internal drug research in 2024 once debt levels are reduced to more favorable levels. Keep in mind that new drug research would come atop existing biosimilar clinical trials, which are expected to generate billions of dollars in future sales.\nViatris won't deliver jaw-dropping growth like Jushi, or even double-digit annual sales upside like Exelixis. But with a steadiness to generic-drug demand and an improving balance sheet, Viatris' forward price-to-earnings ratio below 4 simply doesn't do its stock justice.","news_type":1},"isVote":1,"tweetType":1,"viewCount":618,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":852098147,"gmtCreate":1635220106862,"gmtModify":1635220107062,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Tesla for the win","listText":"Tesla for the win","text":"Tesla for the win","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/852098147","repostId":"2178471618","repostType":4,"isVote":1,"tweetType":1,"viewCount":524,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866077583,"gmtCreate":1632717194842,"gmtModify":1632798328162,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Duolingo is worth a look","listText":"Duolingo is worth a look","text":"Duolingo is worth a look","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/866077583","repostId":"2170108956","repostType":4,"isVote":1,"tweetType":1,"viewCount":478,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866288127,"gmtCreate":1632785111769,"gmtModify":1632797903233,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Aaple Ftw!","listText":"Aaple Ftw!","text":"Aaple Ftw!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/866288127","repostId":"1143344359","repostType":4,"repost":{"id":"1143344359","pubTimestamp":1632727246,"share":"https://www.laohu8.com/m/news/1143344359?lang=&edition=full","pubTime":"2021-09-27 15:20","market":"us","language":"en","title":"Apple Stock: The “Trick” That Can Push Share Price Higher","url":"https://stock-news.laohu8.com/highlight/detail?id=1143344359","media":"TheStreet","summary":"Corporate America continues to aggressively buy their own shares, following a pullback in activity d","content":"<p>Corporate America continues to aggressively buy their own shares, following a pullback in activity during the pandemic. This is how Apple stock investors should benefit.</p>\n<p>S&amp;P Dow Jones Indices has&nbsp;reported&nbsp;that US-based companies continue to invest heavily in… their own stock. Share buybacks in Q2 has risen nearly 12% sequentially and 124% YOY. This is a strong rebound from the post-COVID period of uncertainty that led to a temporary reduction in repurchase activity.</p>\n<p>This is a reminder for Apple stock&nbsp;investors that the Cupertino company’s share price can continue to benefit from stock buybacks. The Apple Maven recaps why this might be the case.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b3facec59ae76a6c28f4c5847600b4de\" tg-width=\"1240\" tg-height=\"886\" width=\"100%\" height=\"auto\"><span>Figure 1: Apple store in New York, NY.</span></p>\n<p><b>Apple’s “secret sauce”</b></p>\n<p>A bit over a year ago,I talked about one of Apple’s tricks&nbsp;to driving share price higher in the past decade. “Tenfold in ten years” was possible not merely because of robust business fundamentals. Sure, the popularity of the iPhone and success of iPad contributed greatly to compelling stock performance. But share repurchase was also an important piece of the puzzle.</p>\n<p>Think about it: since 2011, Apple’s net income grew an impressive 190%. But at the same time, EPS (earnings per share) shot up by 325% over the same period. This “net income leverage” effect was only possible because share count was slashed by around 30% between 2013 and 2020. See chart below, which was published in June 2020 and not adjusted&nbsp;for the most recent stock split.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/10126c1a8a7f21648f44ba54c038c518\" tg-width=\"656\" tg-height=\"352\" width=\"100%\" height=\"auto\"><span>Figure 2: Apple's net cash &amp; shares outstanding since 2011.</span></p>\n<p>In the S&amp;P’s most recent report, Apple was cited as the leader of the pack in stock buybacks by “not only spending the most of any [company], but its Q2 expenditure ranked second highest in S&amp;P history”. The Cupertino company seems highly committed to supporting its stock, which should be a bullish sign.</p>\n<p><b>Apple Maven’s take: quick math</b></p>\n<p>Continuing to retire shares is, in my view, a crucial tenet of the investment thesis on AAPL stock – and Apple’s management team seems to agree. Year-to-date, the Cupertino company has&nbsp;spent&nbsp;$66.2 billion on repurchases, 20% more than in fiscal 2020. The figure is massive, as it has represented nearly 90% of the free cash flow that Apple has produced in fiscal 2021 so far.</p>\n<p>At this pace, and assuming a share price of $150 apiece, Apple can retire around 600 million shares per year going forward, or just short of 4% of the total number of shares outstanding annually. Give it five years, and Apple’s share count could drop by almost 20%.</p>\n<p>Think of the EPS calculation, which is net income divided by shares outstanding. Repurchases alone can boost Apple’s bottom line quite substantially. Assuming the stock’s P/E valuation does not change, it is fair to say, roughly, that AAPL stock can rise some 20% by 2026 due to buybacks alone.</p>\n<p>For this reason and given the recent reports of a pickup in share repurchase activity across Corporate America, Apple investors have good reasons to be optimistic about share price performance.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock: The “Trick” That Can Push Share Price Higher</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock: The “Trick” That Can Push Share Price Higher\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-27 15:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/stock/apple-stock-the-trick-that-can-push-share-price-higher><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Corporate America continues to aggressively buy their own shares, following a pullback in activity during the pandemic. This is how Apple stock investors should benefit.\nS&P Dow Jones Indices has ...</p>\n\n<a href=\"https://www.thestreet.com/apple/stock/apple-stock-the-trick-that-can-push-share-price-higher\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/stock/apple-stock-the-trick-that-can-push-share-price-higher","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143344359","content_text":"Corporate America continues to aggressively buy their own shares, following a pullback in activity during the pandemic. This is how Apple stock investors should benefit.\nS&P Dow Jones Indices has reported that US-based companies continue to invest heavily in… their own stock. Share buybacks in Q2 has risen nearly 12% sequentially and 124% YOY. This is a strong rebound from the post-COVID period of uncertainty that led to a temporary reduction in repurchase activity.\nThis is a reminder for Apple stock investors that the Cupertino company’s share price can continue to benefit from stock buybacks. The Apple Maven recaps why this might be the case.\nFigure 1: Apple store in New York, NY.\nApple’s “secret sauce”\nA bit over a year ago,I talked about one of Apple’s tricks to driving share price higher in the past decade. “Tenfold in ten years” was possible not merely because of robust business fundamentals. Sure, the popularity of the iPhone and success of iPad contributed greatly to compelling stock performance. But share repurchase was also an important piece of the puzzle.\nThink about it: since 2011, Apple’s net income grew an impressive 190%. But at the same time, EPS (earnings per share) shot up by 325% over the same period. This “net income leverage” effect was only possible because share count was slashed by around 30% between 2013 and 2020. See chart below, which was published in June 2020 and not adjusted for the most recent stock split.\nFigure 2: Apple's net cash & shares outstanding since 2011.\nIn the S&P’s most recent report, Apple was cited as the leader of the pack in stock buybacks by “not only spending the most of any [company], but its Q2 expenditure ranked second highest in S&P history”. The Cupertino company seems highly committed to supporting its stock, which should be a bullish sign.\nApple Maven’s take: quick math\nContinuing to retire shares is, in my view, a crucial tenet of the investment thesis on AAPL stock – and Apple’s management team seems to agree. Year-to-date, the Cupertino company has spent $66.2 billion on repurchases, 20% more than in fiscal 2020. The figure is massive, as it has represented nearly 90% of the free cash flow that Apple has produced in fiscal 2021 so far.\nAt this pace, and assuming a share price of $150 apiece, Apple can retire around 600 million shares per year going forward, or just short of 4% of the total number of shares outstanding annually. Give it five years, and Apple’s share count could drop by almost 20%.\nThink of the EPS calculation, which is net income divided by shares outstanding. Repurchases alone can boost Apple’s bottom line quite substantially. Assuming the stock’s P/E valuation does not change, it is fair to say, roughly, that AAPL stock can rise some 20% by 2026 due to buybacks alone.\nFor this reason and given the recent reports of a pickup in share repurchase activity across Corporate America, Apple investors have good reasons to be optimistic about share price performance.","news_type":1},"isVote":1,"tweetType":1,"viewCount":655,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":868655227,"gmtCreate":1632644062369,"gmtModify":1632646786154,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"What did i just see?? Wow","listText":"What did i just see?? Wow","text":"What did i just see?? Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/868655227","repostId":"1135042460","repostType":4,"repost":{"id":"1135042460","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1632299463,"share":"https://www.laohu8.com/m/news/1135042460?lang=&edition=full","pubTime":"2021-09-22 16:31","market":"us","language":"en","title":"Elon Musk Hopes To Roll Out Tesla Insurance Worldwide, Beginning With Texas Next Month, But Says Regulations Present Massive Challenge","url":"https://stock-news.laohu8.com/highlight/detail?id=1135042460","media":"Benzinga","summary":"Tesla Inc is planning on offering car insurance, \"based on actual driving history,\" in Texas next mo","content":"<p><b>Tesla Inc</b>&nbsp;is planning on offering car insurance, \"based on actual driving history,\" in Texas next month, as per the company’s CEO<b>Elon Musk.</b></p>\n<p><b>What Happened:</b>The electric vehicle manufacturer, which already offers insurance in California, is hoping to jump into the insurance fray in Texas next month and anticipates&nbsp;approval in New York next year, Musk said.</p>\n<p>The entrepreneur noted that the regulatory process for approval to offer insurance is “extremely slow &amp; complex” and varies considerably by state.</p>\n<p>Notably, Musk’s comments came in response to a Tesla user who said on Twitter he was quoted $500 per month for a Model Y car.</p>\n<p><img src=\"https://static.tigerbbs.com/1594c43528174e6cbf1c3a23e173a981\" tg-width=\"563\" tg-height=\"538\" width=\"100%\" height=\"auto\">Separately, Musk also said on Twitter that Tesla would hopefully roll out the product worldwide in the long term.</p>\n<p><img src=\"https://static.tigerbbs.com/f12a3a011bfd78c1b97ada0895522b26\" tg-width=\"564\" tg-height=\"368\" width=\"100%\" height=\"auto\"><b>Why It Matters:</b>&nbsp;Tesla Insurance wasrolled out in California in August 2019. At the time, it was reported that the company’s coverage was up to 30% less expensive in some instances.</p>\n<p>At the time, industry analysts said that the Tesla insurance product wasn’t likely to massively disrupt the insurance sector.</p>\n<p>An app data leak, reported in June, found code that indicated rates for insurancewould be adjustedbased on time spent using autopilot, speed, miles driven per day, and other statistics.</p>\n<p><b>Price Action:</b>&nbsp;On Tuesday, Tesla shares closed nearly 1.3% higher at $739.38 in the regular session and fell 0.32% in the after-hours trading.</p>\n<p><img src=\"https://static.tigerbbs.com/cb374747ef66ac69cbd6d8e11ccbb8c1\" tg-width=\"993\" tg-height=\"568\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elon Musk Hopes To Roll Out Tesla Insurance Worldwide, Beginning With Texas Next Month, But Says Regulations Present Massive Challenge</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElon Musk Hopes To Roll Out Tesla Insurance Worldwide, Beginning With Texas Next Month, But Says Regulations Present Massive Challenge\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-09-22 16:31</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Tesla Inc</b>&nbsp;is planning on offering car insurance, \"based on actual driving history,\" in Texas next month, as per the company’s CEO<b>Elon Musk.</b></p>\n<p><b>What Happened:</b>The electric vehicle manufacturer, which already offers insurance in California, is hoping to jump into the insurance fray in Texas next month and anticipates&nbsp;approval in New York next year, Musk said.</p>\n<p>The entrepreneur noted that the regulatory process for approval to offer insurance is “extremely slow &amp; complex” and varies considerably by state.</p>\n<p>Notably, Musk’s comments came in response to a Tesla user who said on Twitter he was quoted $500 per month for a Model Y car.</p>\n<p><img src=\"https://static.tigerbbs.com/1594c43528174e6cbf1c3a23e173a981\" tg-width=\"563\" tg-height=\"538\" width=\"100%\" height=\"auto\">Separately, Musk also said on Twitter that Tesla would hopefully roll out the product worldwide in the long term.</p>\n<p><img src=\"https://static.tigerbbs.com/f12a3a011bfd78c1b97ada0895522b26\" tg-width=\"564\" tg-height=\"368\" width=\"100%\" height=\"auto\"><b>Why It Matters:</b>&nbsp;Tesla Insurance wasrolled out in California in August 2019. At the time, it was reported that the company’s coverage was up to 30% less expensive in some instances.</p>\n<p>At the time, industry analysts said that the Tesla insurance product wasn’t likely to massively disrupt the insurance sector.</p>\n<p>An app data leak, reported in June, found code that indicated rates for insurancewould be adjustedbased on time spent using autopilot, speed, miles driven per day, and other statistics.</p>\n<p><b>Price Action:</b>&nbsp;On Tuesday, Tesla shares closed nearly 1.3% higher at $739.38 in the regular session and fell 0.32% in the after-hours trading.</p>\n<p><img src=\"https://static.tigerbbs.com/cb374747ef66ac69cbd6d8e11ccbb8c1\" tg-width=\"993\" tg-height=\"568\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135042460","content_text":"Tesla Inc is planning on offering car insurance, \"based on actual driving history,\" in Texas next month, as per the company’s CEOElon Musk.\nWhat Happened:The electric vehicle manufacturer, which already offers insurance in California, is hoping to jump into the insurance fray in Texas next month and anticipates approval in New York next year, Musk said.\nThe entrepreneur noted that the regulatory process for approval to offer insurance is “extremely slow & complex” and varies considerably by state.\nNotably, Musk’s comments came in response to a Tesla user who said on Twitter he was quoted $500 per month for a Model Y car.\nSeparately, Musk also said on Twitter that Tesla would hopefully roll out the product worldwide in the long term.\nWhy It Matters: Tesla Insurance wasrolled out in California in August 2019. At the time, it was reported that the company’s coverage was up to 30% less expensive in some instances.\nAt the time, industry analysts said that the Tesla insurance product wasn’t likely to massively disrupt the insurance sector.\nAn app data leak, reported in June, found code that indicated rates for insurancewould be adjustedbased on time spent using autopilot, speed, miles driven per day, and other statistics.\nPrice Action: On Tuesday, Tesla shares closed nearly 1.3% higher at $739.38 in the regular session and fell 0.32% in the after-hours trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":368,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":824103123,"gmtCreate":1634285830465,"gmtModify":1634285830574,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Not every earnings season is the&nbsp;same, and most forecast dun run true","listText":"Not every earnings season is the&nbsp;same, and most forecast dun run true","text":"Not every earnings season is the same, and most forecast dun run true","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/824103123","repostId":"1123139232","repostType":4,"isVote":1,"tweetType":1,"viewCount":562,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865402199,"gmtCreate":1633008831674,"gmtModify":1633008831859,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Well, a good read","listText":"Well, a good read","text":"Well, a good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865402199","repostId":"2171986054","repostType":4,"repost":{"id":"2171986054","pubTimestamp":1632973200,"share":"https://www.laohu8.com/m/news/2171986054?lang=&edition=full","pubTime":"2021-09-30 11:40","market":"us","language":"en","title":"3 Vanguard ETFs I'm Buying if the Stock Market Crashes","url":"https://stock-news.laohu8.com/highlight/detail?id=2171986054","media":"Motley Fool","summary":"Nobody knows whether the market will crash. But if it does, I'm stocking up on these investments.","content":"<blockquote>\n <b>Nobody knows whether the market will crash. But if it does, I'm stocking up on these investments.</b>\n</blockquote>\n<p><b>Key Points</b></p>\n<ul>\n <li>The Vanguard S&amp;P 500 ETF can be a great option for withstanding market volatility.</li>\n <li>The Vanguard Total Stock Market ETF can help reduce your risk.</li>\n <li>The Vanguard Growth ETF can supercharge your investments.</li>\n</ul>\n<p>Over the past year and a half, the stock market has experienced <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the greatest growth streaks in history. The <b>S&amp;P 500</b> is up nearly 100% since March 2020, and investors have seen their portfolios skyrocket during that time.</p>\n<p>Some experts believe, however, that it's only a matter of time before prices fall. Market downturns may be intimidating, but they're normal. In fact, it's healthy for the market to experience corrections every so often, because stock prices can't continue climbing forever.</p>\n<p>Nobody knows for sure whether a crash is on the horizon, or, if it does happen, how significant it will be. However, if the market does take a turn for the worse, there are a few exchange-traded funds (ETFs) I'll be buying.</p>\n<p><img src=\"https://static.tigerbbs.com/9c5cb96961b54db9d77a960894b88df7\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>1. Vanguard S&amp;P 500 ETF (VOO)</h3>\n<p>It may seem counterintuitive to buy when the market is down, but crashes can be a fantastic opportunity to invest when prices are lower. ETFs trade like stocks, so when the market is down, their share prices are typically lower as well.</p>\n<p>One ETF I'm planning to invest in heavily if the market crashes is the <b>Vanguard S&amp;P 500 ETF</b> (NYSEMKT:VOO). Like its name suggests, this fund tracks the S&amp;P 500 and includes all the stocks within the index itself.</p>\n<p>The S&amp;P 500 ETF is one of the most dependable investments out there. Historically, the index itself has faced countless crashes and corrections, and it has recovered from each and every one. If the market crashes again, there's a very good chance this ETF will be able to bounce back. And by buying when prices are lower, you'll reap the rewards once the market recovers and prices increase once again.</p>\n<h3>2. Vanguard Total Stock Market ETF (VTI)</h3>\n<p>The <b>Vanguard Total Stock Market ETF</b> (NYSEMKT:VTI) is similar to the S&amp;P 500 ETF, but it includes more stocks from more diverse companies.</p>\n<p>The S&amp;P 500 ETF includes stocks from 500 large companies, while the Total Stock Market ETF includes nearly 4,000 stocks from small, midsize, and large corporations. This provides greater diversification and can decrease your risk.</p>\n<p>Another advantage of this fund is that it's designed to follow the market as a whole. Again, the stock market has a strong track record when it comes to recovering from downturns, so by investing in this ETF, it's likely your investments will recover as well.</p>\n<h3>3. Vanguard Growth ETF (VUG)</h3>\n<p>The <b>Vanguard Growth ETF</b> (NYSEMKT:VUG) includes 285 stocks from companies that are expected to grow at a faster-than-average pace.</p>\n<p>This fund includes the fewest holdings of the three ETFs on the list, which does make it slightly riskier. However, many of the biggest stocks in the fund are from behemoth tech corporations like <b>Amazon</b>, <b>Apple</b>, and <b>Microsoft</b> -- companies that are very likely to survive market volatility.</p>\n<p>One of the primary advantages of growth ETFs is that they're designed to earn above-average returns. This particular ETF has earned an average rate of return of around 12% per year since its inception, for example. By comparison, the S&amp;P 500 has historically earned a 10% average annual return, and the Vanguard Total Stock Market ETF has earned an average return of around 9% per year.</p>\n<p>Investing in ETFs can be a fantastic way to build wealth with less effort, and buying during a market downturn can make investing more affordable. While nobody knows for certain whether a market crash is coming, by making a list now of the investments you want to buy, you can snag them at a discount later.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Vanguard ETFs I'm Buying if the Stock Market Crashes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Vanguard ETFs I'm Buying if the Stock Market Crashes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-30 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/29/3-vanguard-etfs-buy-if-the-stock-market-crashes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nobody knows whether the market will crash. But if it does, I'm stocking up on these investments.\n\nKey Points\n\nThe Vanguard S&P 500 ETF can be a great option for withstanding market volatility.\nThe ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/29/3-vanguard-etfs-buy-if-the-stock-market-crashes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SSO":"两倍做多标普500ETF",".SPX":"S&P 500 Index","OEX":"标普100","IVV":"标普500指数ETF","VUG":"成长股指数ETF-Vanguard MSCI","UPRO":"三倍做多标普500ETF","SPY":"标普500ETF","OEF":"标普100指数ETF-iShares","SH":"标普500反向ETF","SPXU":"三倍做空标普500ETF","VOO":"Vanguard标普500ETF","VTI":"大盘指数ETF-Vanguard MSCI","SDS":"两倍做空标普500ETF"},"source_url":"https://www.fool.com/investing/2021/09/29/3-vanguard-etfs-buy-if-the-stock-market-crashes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2171986054","content_text":"Nobody knows whether the market will crash. But if it does, I'm stocking up on these investments.\n\nKey Points\n\nThe Vanguard S&P 500 ETF can be a great option for withstanding market volatility.\nThe Vanguard Total Stock Market ETF can help reduce your risk.\nThe Vanguard Growth ETF can supercharge your investments.\n\nOver the past year and a half, the stock market has experienced one of the greatest growth streaks in history. The S&P 500 is up nearly 100% since March 2020, and investors have seen their portfolios skyrocket during that time.\nSome experts believe, however, that it's only a matter of time before prices fall. Market downturns may be intimidating, but they're normal. In fact, it's healthy for the market to experience corrections every so often, because stock prices can't continue climbing forever.\nNobody knows for sure whether a crash is on the horizon, or, if it does happen, how significant it will be. However, if the market does take a turn for the worse, there are a few exchange-traded funds (ETFs) I'll be buying.\n\nImage source: Getty Images.\n1. Vanguard S&P 500 ETF (VOO)\nIt may seem counterintuitive to buy when the market is down, but crashes can be a fantastic opportunity to invest when prices are lower. ETFs trade like stocks, so when the market is down, their share prices are typically lower as well.\nOne ETF I'm planning to invest in heavily if the market crashes is the Vanguard S&P 500 ETF (NYSEMKT:VOO). Like its name suggests, this fund tracks the S&P 500 and includes all the stocks within the index itself.\nThe S&P 500 ETF is one of the most dependable investments out there. Historically, the index itself has faced countless crashes and corrections, and it has recovered from each and every one. If the market crashes again, there's a very good chance this ETF will be able to bounce back. And by buying when prices are lower, you'll reap the rewards once the market recovers and prices increase once again.\n2. Vanguard Total Stock Market ETF (VTI)\nThe Vanguard Total Stock Market ETF (NYSEMKT:VTI) is similar to the S&P 500 ETF, but it includes more stocks from more diverse companies.\nThe S&P 500 ETF includes stocks from 500 large companies, while the Total Stock Market ETF includes nearly 4,000 stocks from small, midsize, and large corporations. This provides greater diversification and can decrease your risk.\nAnother advantage of this fund is that it's designed to follow the market as a whole. Again, the stock market has a strong track record when it comes to recovering from downturns, so by investing in this ETF, it's likely your investments will recover as well.\n3. Vanguard Growth ETF (VUG)\nThe Vanguard Growth ETF (NYSEMKT:VUG) includes 285 stocks from companies that are expected to grow at a faster-than-average pace.\nThis fund includes the fewest holdings of the three ETFs on the list, which does make it slightly riskier. However, many of the biggest stocks in the fund are from behemoth tech corporations like Amazon, Apple, and Microsoft -- companies that are very likely to survive market volatility.\nOne of the primary advantages of growth ETFs is that they're designed to earn above-average returns. This particular ETF has earned an average rate of return of around 12% per year since its inception, for example. By comparison, the S&P 500 has historically earned a 10% average annual return, and the Vanguard Total Stock Market ETF has earned an average return of around 9% per year.\nInvesting in ETFs can be a fantastic way to build wealth with less effort, and buying during a market downturn can make investing more affordable. While nobody knows for certain whether a market crash is coming, by making a list now of the investments you want to buy, you can snag them at a discount later.","news_type":1},"isVote":1,"tweetType":1,"viewCount":451,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":868655841,"gmtCreate":1632644034883,"gmtModify":1632646789155,"author":{"id":"3585005453956722","authorId":"3585005453956722","name":"JTWealth","avatar":"https://static.tigerbbs.com/b210c979fe489ad571406208c0ccd5d9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Oh yeahhhh","listText":"Oh yeahhhh","text":"Oh yeahhhh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/868655841","repostId":"1136461867","repostType":4,"repost":{"id":"1136461867","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632405237,"share":"https://www.laohu8.com/m/news/1136461867?lang=&edition=full","pubTime":"2021-09-23 21:53","market":"other","language":"en","title":"Novavax surged over 10% in early trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1136461867","media":"Tiger Newspress","summary":"(Sept 23) Novavax surged over 10% in early trading. Novavax Announce Submission to World Health Orga","content":"<p>(Sept 23)&nbsp;<b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a> </b>surged over 10% in early trading.&nbsp;Novavax Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine.</p>\n<p><img src=\"https://static.tigerbbs.com/38fe74a02950ee20c0a498be55a8e0a4\" tg-width=\"958\" tg-height=\"563\" referrerpolicy=\"no-referrer\"></p>\n<p>Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, with its partner, Serum Institute of India Pvt. Ltd. (SII), today announced a regulatory submission to the World Health Organization (WHO) for emergency use listing (EUL) of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine candidate with Matrix-M™ adjuvant. The submission to WHO is based on the companies' previous regulatory submission to the Drugs Controller General ofIndia(DCGI).</p>\n<p>\"Today's submission of our protein-based COVID-19 vaccine to WHO for emergency use listing is a significant step on the path to accelerating access and more equitable distribution to countries in great need around the world,\" saidStanley C. Erck, President and Chief Executive Officer, Novavax. \"It represents another major milestone in Novavax' transformation into a commercial global vaccine company and reinforces the value of global collaboration and need for multiple approaches to help control the pandemic.\"</p>\n<p>The grant of EUL by the WHO is a prerequisite for exports to numerous countries participating in the COVAX Facility, which was established to allocate and distribute vaccines equitably to participating countries and economies. In addition to the submission for WHO EUL, SII and Novavax last month completed the submission of modules required by regulatory agencies inIndia,Indonesiaandthe Philippinesfor the initiation of review of the vaccine, including preclinical, clinical, and chemistry, manufacturing and controls (CMC) data.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax surged over 10% in early trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax surged over 10% in early trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-23 21:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Sept 23)&nbsp;<b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a> </b>surged over 10% in early trading.&nbsp;Novavax Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine.</p>\n<p><img src=\"https://static.tigerbbs.com/38fe74a02950ee20c0a498be55a8e0a4\" tg-width=\"958\" tg-height=\"563\" referrerpolicy=\"no-referrer\"></p>\n<p>Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, with its partner, Serum Institute of India Pvt. Ltd. (SII), today announced a regulatory submission to the World Health Organization (WHO) for emergency use listing (EUL) of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine candidate with Matrix-M™ adjuvant. The submission to WHO is based on the companies' previous regulatory submission to the Drugs Controller General ofIndia(DCGI).</p>\n<p>\"Today's submission of our protein-based COVID-19 vaccine to WHO for emergency use listing is a significant step on the path to accelerating access and more equitable distribution to countries in great need around the world,\" saidStanley C. Erck, President and Chief Executive Officer, Novavax. \"It represents another major milestone in Novavax' transformation into a commercial global vaccine company and reinforces the value of global collaboration and need for multiple approaches to help control the pandemic.\"</p>\n<p>The grant of EUL by the WHO is a prerequisite for exports to numerous countries participating in the COVAX Facility, which was established to allocate and distribute vaccines equitably to participating countries and economies. In addition to the submission for WHO EUL, SII and Novavax last month completed the submission of modules required by regulatory agencies inIndia,Indonesiaandthe Philippinesfor the initiation of review of the vaccine, including preclinical, clinical, and chemistry, manufacturing and controls (CMC) data.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136461867","content_text":"(Sept 23) Novavax surged over 10% in early trading. Novavax Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine.\n\nNovavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, with its partner, Serum Institute of India Pvt. Ltd. (SII), today announced a regulatory submission to the World Health Organization (WHO) for emergency use listing (EUL) of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine candidate with Matrix-M™ adjuvant. The submission to WHO is based on the companies' previous regulatory submission to the Drugs Controller General ofIndia(DCGI).\n\"Today's submission of our protein-based COVID-19 vaccine to WHO for emergency use listing is a significant step on the path to accelerating access and more equitable distribution to countries in great need around the world,\" saidStanley C. Erck, President and Chief Executive Officer, Novavax. \"It represents another major milestone in Novavax' transformation into a commercial global vaccine company and reinforces the value of global collaboration and need for multiple approaches to help control the pandemic.\"\nThe grant of EUL by the WHO is a prerequisite for exports to numerous countries participating in the COVAX Facility, which was established to allocate and distribute vaccines equitably to participating countries and economies. In addition to the submission for WHO EUL, SII and Novavax last month completed the submission of modules required by regulatory agencies inIndia,Indonesiaandthe Philippinesfor the initiation of review of the vaccine, including preclinical, clinical, and chemistry, manufacturing and controls (CMC) data.","news_type":1},"isVote":1,"tweetType":1,"viewCount":198,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}